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ABSTRACT
Phosphate transfer is ubiquitous in nature, however the occurance of phosphomutases is
rare. Their uniqueness can be attributed to the complex and malleable substrate recog-
nition scheme that allows the enzyme to perform two similar, yet distinct, catalytic steps
while maintaining strict fidelity for substrate versus water. The complexity of developing
this mechanism is highlighted in that, while phosphomutase function has independently
evolved in most larger phosphotransferase superfamilies, very little diversification of this
function has developed. As such, phosphomutases provide a rich framework to study the
intricate specificity mechanisms employed by enzymes.
β-Phosphoglucomutase (βPGM) catalyzes the interconversion between β-glucose 1-
phosphate (βG1P) and glucose 6-phosphate (G6P) via a β-glucose 1,6 bisphosphate
(βG16P) intermediate. βPGM is in one of two subfamilies that have independently
acquired phosphomutase activity within the ubiquitous Haloalkanoate Dehalogenase
superfamily (HADSF) of phosphotransferases. The enzyme has been observed to undergo
a large conformational change upon binding βG16P as well as a repositioning of the
general acid/base catalyst residue Asp10. In addition, the mechanism involves cycling of
the protonation state of Asp10, which requires a significant pKa shift. The importance
vii
of Asp10 and its activation of the enzyme have been discussed previously, however a
clear understanding of the interplay between the conformational and catalytic activation
mechanisms for βPGM has not been described.
This work uses aqueous phase techniques, solution X-ray scattering and molecular
dynamics, to probe the effect of individual ligand moieties on the conformational state of
the enzyme and free energy molecular dynamics and electrostatic calculations determine
the interplay between conformation, protonation and Asp10 activation. The results
implicate a model where the ligand-induced conformational change is governed by the
non-catalytic phosphate site, and this transition induces correct positioning of Asp10,
which, in turn induces the pKa shift, forming the catalytically competent complex.
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1Chapter 1
Evolution of Mutase Function from a Phosphatase Scaffold
1.1 Rarity and Intricacy of Phosphomutase Mechanisms
Despite the prevalence of phosphate transfer enzymes, the phenomena of phosphomutases,
enzymes that transfer phosphate from one position on a substrate to another position, is
rare [1]. Compared to the seven-hundred kinase and phosphatase enzymes characterized,
only ten distinct phosphomutases have been described thus far in nature1. The distinction
between a phosphotransferase and phosphomutase lies in the ability of a mutase to dis-
criminate between substrate and solvent following dephosphorylation of the target ligand
and the ability to perform the phosphoryl transfer step nearly equally well at multiple sites
on the target ligand. The rarity of this function may be due to the complex mechanism
required to perform two distinct catalytic events on the same enzyme scaffold. This implies
a certain balance in the substrate specificity machinery of the enzyme; it must be malleable
enough to accept both orientations of the substrate in the same active site, while maintan-
ing high fidelity for substrate over water. As such, mutases provide a rich framework for
understanding strategies of substrate recognition in enzymes.
The complexity of developing mutase activity is highlighted in the observation that, while
phosphomutase function has evolved in most of the larger phosphotransferase superfami-
lies [25], there has not been a broad development of phosphomutase activity within these
superfamilies. The α-D-phosphohexomutase superfamily has developed four distinct speci-
ficities using the same scaffold and 2,3 BPG independent phosphoglycerate mutase and bis-
phosphoglycerate mutase share the same mechanism derived from the histidine phosphatase
scaffold [2]. Phosphogylcerate mutases are unique, as they perform an initial dephosphory-
lation step and subsequent reorientation of the ligand in the closed active site [2]. In the
1As assessed by EC classification 5.4.2.X
2remaining phosphomutases with larger substrate scaffolds, the phosphoenzyme is the active
state, with an initial phosphorylation of the ligand, while reorientation is accompanied by
a conformational change. In these enzymes with larger substrates, where the active enzyme
is has a free phosphate, strategies must be employed to prevent transfer of this phosphate
to solvent when in the unbound state.
In contrast, the enzymes of the α-D-phosphohexomutase superfamily are able to hold on
to their phosphate groups by utilizing a phosphoserine intermediate that is resistant to
hydrolysis at alkaline pH [6]. In addition, the bisphosphorylated hexose intermediate is
observed to remain in the active site between catalytic steps [7], so reorientation and re-
binding of the substrate is not a rate-limiting step. The balance of phosphomutase enzymes,
including the subject of this study, reside in the Haloalkanoate Dehalogenase superfamily
of phosphotransferases.
1.2 Importance and Ubiquity of the Haloalkanoate Dehalogenase Super-
family
The Haloalkanoate Dehalogenase superfamily (HADSF) is a ubiquitous set of enzymes that
perform mainly hydrolase chemistry on small metabolites [8]. Members of the HADSF
exist in every organism and comprise over 50% of the phosphate transfer enzymes in the
prokaryotic metabolome.
The catalytic mechanism in the HADSF phosphatases is performed by an active site
aspartate nucleophile, which is mediated by a second aspartate two residues downstream,
the Asp+2 residue, that functions as a general acid/base catalyst. This DXD motif
comprises part of the catalytic core of the enzyme, which is contained in a Rossmann
fold [9]. Other conserved motifs from different parts of the core domain as well as a
required Mg2+ cofactor comprise the phosphate-binding site where the transfer chemistry
occurs [10]. Though sequence conservation of the Rossmann fold outside of the catalytic
motifs is not great across HADSF members, structural similarity is found to be high [11].
3In most HADSF members, the phosphoryl transfer to the nucleophilic aspartate is mediated
by the Asp+2 functioning as a general-acid catalyst, protonating the leaving group, which
is subsequently released. Release of the leaving group opens the active site to solvent,
where upon the aspartylphosphate is hydrolyzed, with the Asp+2 residue acting as a
general base, accelerating the hydrolysis reaction by a factor 103 to 104 [10]. The carboxyl
group of the Asp+2 is observed to make a hydrogen bond to another core domain residue
in most HADSF members, fixing the residue in the active position to facilitate proton
transfer [1214].
HADSF members can be classified based on their presentation of a second cap domain,
found as an insert into one of the loops of the Rossman fold core [Figure 1.1]. Type C0
caps are minimal inserts, while type C1 caps are comprised of a four helix bundle inserted
six residues after the DXD motif. Type C2a and C2b caps are inserted farther downstream
and contain two different α/β topologies. The cap domain has been implicated in substrate
specificity and active-site desolvation [15] with the ligand binding at the interface of the
two domains and crystallographic observation of a concurrent conformational change [16,17].
4Figure 1.1: Cap Domain Subfamilies in Haloalkanoate Dehalogenase Superfamily.
Figure courtesy of Dr. Nick Silvaggi.
Despite the ubiquity of the HADSF in phosphoryl transfer, only two phosphomutase sub-
families exist in the HADSF, and each in distant phyla: phosphomannomutase; a C2a
member which contains two phosphomannose isoforms, PMM1 and PMM2 as well as a re-
lated α-phosphoglucomutase isoform and β-phosphoglucomutase, a C1 cap member evolved
from phosphoglycolate phosphatase family.
1.3 β Phosphoglucomutase Mechanism and Structure
β-phosphoglucomutase (βPGM) is the only known instance of a C1 HAD member that
has evolved mutase activity. The enzyme catalyzes the interconversion between β-glucose
1-phosphate (βG1P) and glucose 6-phosphate (G6P) via a β-glucose 1,6 bisphosphate
intermediate (βG16P). Unlike the α-phosphohexomutases, βG16P is observed to dissociate
from the active site,utilizing a bi-bi ping-pong mechanism, with the majority of turnover
5occurring from a new βG16P entering the active site [18]. The phosphate transfer
mechanism is analagous to that in other HAD members, performed through a nucleophilic
aspartate residue in the core region of the enzyme and catalyzed via a general acid/base
aspartate residue located two positions downstream. The utilization of an aspartate
residue is not ideal for mutase chemistry, however, as water can spontaneously hydrolyze
phosphoaspartate [19]. βPGM, however, shows high fidelity for substrate over water, with
phosphate transfer to G1P occurring 400 fold faster than to water [18].
βPGM from Lactococcus lactis has been observed crystallographically to undergo a large
conformational change [Fig. 1.2(a)] upon binding its natural substrate, βglucose 1,6
bisphophate [17, 20] or G6P/βG1P and planar phosphite mimic beryllium trifluoride [21].
This conformational change proceeds as a rigid-body translation, with the cap and core
domains rotating 23◦ together in a hinge-like motion. A major structural difference
that is not observed in HAD hydrolases is a rotation of the critical Asp+2 acid/base
catalyst carboxyl (Asp10 in the L. lactis isoform) in the open, unliganded form of the
enzyme [Fig 1.2(b)]. This 120◦ swing along the Cα-Cβ positions the carboxyl too far
from the phosphoryl group to assist in phosphate transfer. It is this swinging Asp10
that is implicated in determining the activation state of the enzyme and ensuring that
the free phosphoaspartate is not hydrolyzed [22]. Notably, the other HAD mutase,
PMM, has also been observed with its Asp+2 catalyst swung out of the active site, how-
ever the corresponding structure with the transition state mimic has not been observed [23].
The ligand binding pocket of βPGM consists of three parts: the transferring phosphate
site, sugar site and distal binding site [Fig 1.2(b)]. A βG16P can bind to the unphospho-
rylated enzyme, with either the 1 or 6 phosphate occupying the transferring site, with the
other phosphate bound in the distal site. The Asp8 phosphorylated enzyme can bind either
βG1P or G6P with its phosphate bound in the transferring site. The transferring phosphate
is coordinated solely by moieties in the core domain: the carboxyl of Asp10, hydroxyl of
6Ser114 and the Mg2+ cofactor. The sugar hydroxyls make no specific connections to the
enzyme, however His20 appears to make a ring stacking interaction. The distal phosphate
is coordinated by groups in both the core domain through the carboxamide of Asn118 and
the cap domain via the guanidium of Arg49 [Fig 1.2(b)]. In the open configuration of the
enzyme, the distal site is disordered, with two phosphate coordinating sidechains having
moved 3 angstroms farther apart, while the transferring site remains unchanged between
the two conformations [Fig 1.2(b)].
Figure 1.2: Conformational change of βPGM. (a): Overlay of unliganded, open
(blue; PDB 1ZOL) and closed, transition state bound (red; PDB 1O03) minimized
crystal structures of βPGM, superimposed over the core Rossman fold of the enzyme.
The ligand G16P is shown in the active site of the closed structure. (b): Close-up of
ligand and active site residues in the closed state (cyan) and open state (blue). The
active site components are shaded blue (transferring phosphate), green (sugar) and
orange (distal phosphate). Figure made using VMD
This work studies the interplay between substrate binding, conformational change and
7the repositioning of the Asp+2 catalyst in the effort to understand the complex mechanism
by which βPGM has attained phosphomutase activity. A detailed investigation of the
specific protein and substrate interactions that govern the conformational change will be
discussed, followed by an analysis of the conformational state and protonation state of
Asp10 on the positioning of the catalytic carboxyl. The results will be synthesized into a
model describing the sequence of regulatory events between initial enzyme recognition of
βG16P and formation of the catalytic complex. Finally, the critical residues and motifs
identified in the conformational analysis will be assessed in near neighbors of βPGM to
understand the evolutionary history of this regulatory mechanism.
8Chapter 2
Characterizing the Conformational Shift in βPGM
2.1 Introduction
A landmark review by Jencks [24] discussed the energetics of ligand binding, specifically
implicating interactions between nonreacting portions of the substrate and the enzyme as
providing the driving force for a ligand-induced conformational transition. The utilization
of a portion of the susbtrate binding energy for inducing thermodynamically unfavorable
conformational effects would thus cause the observed binding energy to appear lower than
the actual intrinsic binding energy. A recent review by Amyes and Richard details this
effect in a number of systems, showing the magnitude of this effect to be significant [25].
For instance, the coenzyme A moeity of succinate, which binds to noncatalytic residues by
succinyl-CoA:3-oxoacid coenzyme A transferase (SCOT) was shown to have a 17 kcal/mol
stabilization effect on the transition state as compared to free succinate. The Ki for CoA,
however is found to be in the low millimolar range, indicating that the binding event between
CoA and the ground state of the enzyme is weak, implying that the interactions between
CoA and SCOT are specific to stabilizing the transition state complex [26]. Phosphate
dianion has also been shown to have a large allosteric effect on enzyme activation when
coupled with the binding of a unphosphorylated susbstrate, stabilizing the transition states
of the corresponding unphosphorylated substrates by 11-12 kcal/mol in diverse systems
such as triosephosphate isomerase [27], orotidine 5' monophosphate decarboxylase [28] and
glycerol 3-phosphate dehydrogenase [29].
This effect has also been observed in an enzyme that utilizes a variable capping domain,
separate from the catalytic machinery, to interact with distal portions of the substrate.
Mandelate racemase of the enolase superfamily, catalyzes a reconfiguration around the α-
carboxylate by creating a dianionic enolate intermediate followed by reprotonation of the
9site on a TIM-like α/β barrel scaffold. A second variable domain is observed to interact with
a nonreactive phenyl group, which, along with providing the substrate specificity machinery,
also accounts for a 6 kcal/mol stabilization of the transition-state complex. The segregation
of the catalytic machinery and substrate specificity portions in this enzyme superfamily has
been implicated in allowing the broad diversification of this superfamily.
Another superfamily that contains a substrate specificity loop is the Haloalkanoate
Dehalogenase superfamily (HADSF) of phosphotransferases, which act on a wide range
of small metabolites [8]. A Rossmanoid core domain provides the catalytic residues,
which include a nucleophilic aspartate residue and general acid-base catalyst residue two
positions downstream (Asp+2) as well as a binding site for a divalent magnesium cation [14].
Substrate specificity is provided by residues on a second cap domain, which has been
observed in certain cases to close over the active site in the presence of ligand.
While the principles of ground state-destabilization are implied in the previous discus-
sion, an alternative mechanism of enzyme catalysis, utilizing electrostatic preorganization
offered by Warshel, must be considered [30]. In this understanding, both solvent and en-
zyme are able to stabilize the transition state equally well, given correct dipole alignment.
The acceleration scaffold of the enzymatic environment is the preordered arrangement of
active site dipoles complementary to the transition state. Bulk water must undergo a more
significant reorientation that requires more free energy than the pre-organized enzymatic
environment [30]. The implications of this theory are that the catalytic power is directly a
result of the enzymatic environment, rather than specific substrate-enzyme interactions and
the results offered by Amyes, et. al. [25] can be interpreted to support this hypothesis [31].
The focus of this work on ligand binding and substrate specificity, however, does not
preclude either mechanism for catalytic rate acceleration. The ability for large superfamilies
to perform similar chemistry, utilizing the same active site architecture, on a variety of
distal substrate moeities highlights the decoupled nature of the catalytic and substrate
binding machinery [32]. Thus, specific protein-ligand interactions important in providing
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substrate specificity can be considered, independent of the mechanism by which catalytic
rate acceleration occurs. Detailed investigation to discriminate between the two schemes
is beyond the scope of this work and would require careful simulation of the active site
environment at the quantum level [33].
One of the enzymes that undergoes conformational change in the presence of ligand
is β-phosphoglucomutase (βPGM), which catalyzes the interconversion between β-glucose
1-phosphate (βG1P) and glucose 6-phosphate (G6P), via a β-glucose 1,6 bisphosphate inter-
mediate (βG16P) [34], which is observed to dissociate from the enzyme during the catalytic
cycle. These cap and core domains of βPGM are observed crystallographically to draw
together around βG16P in the active site cleft and exclude water from the active site[Fig
1.1(a)] [20]. The transition has been described as a rigid body motion between domains [22],
with only a 1 Å difference in RMSD observed between the backbone heavy atoms of each
individual domain across all crystal structures of the enzyme.
This conformational transition results in a sequestered active site consisting of three
parts: the transferring phosphate site, sugar site and distal phosphate binding site [Fig
1.1(b)]. The transferring-site residues are contained exclusively in the core domain, while
the distal phosphate site is comprised of residues from both the cap and core domains. The
sugar moeity makes no specific contact to the protein. In the catalytic cycle, two types of
binding events can occur to form the closed state, the binding of a bisphosphorylated sugar
(βG16P) to all three sites simultaneously, and the binding of a monophosphorylated sugar
(βG1P of G6P) to the distal site, while the transferring site is occupied by a phosphorylated
Asp8 residue. The ability of both binding events to induce the catalytically competent
complex of βPGM raises the question of the role of each phosphate site in promoting this
transition.
Though characterization of conformational states in the presence of ligand are observed
at the highest resolution via crystallographic methods, the inability to crystallize certain
liganded states, as well as the conformational changes induces by crystal packing somewhat
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limit its use. Small angle X-ray scattering (SAXS), developed prior to crystallography [35],
provides low-resolution solution phase data of the overall size and shape of a macromolecule
and has recently seen an increase in use to structurally characterize macromolecules. SAXS,
unlike crystallography, is a contrast method which utilizes the difference in average electron
density between water (ρs∼0.33 e−/ Å3) and proteins (ρ(r)∼0.44 e−/ Å3). The scattering
signal of a macromolecule in solution can be determined by subtracting out the scattering
component of the solvent. In practice, two scattering measurements are taken, one of the
macromolecular solution, and one of the pure buffer and the two are subtracted to produce
the scattering profile of the macromolecule. The lack of a crystal lattice results in circularly
isotropic data, since the random orintation of particles in solution are simultaneously ob-
served. The resulting data is, then, circularly isotropic and rotationally averaged to create a
1D scattering intensity of the macromolecule, I(q), as a function of the momentum transfer,
q = (4pisinθ)/λ, where 2θ is the scattering angle and λ is the incident wavelength. The
scattering intensity of a macromolecule can be calculated as a function of the electron dis-
tribution of the particle, represented as the pairwise distance distribution function between
electrons, P (r) [36].
I(q) = 4pi
∫ Dmax
0
P (r)
sin(qr)
qr]
dr (2.1)
where Dmax is the largest dimension of the particle.
The one-dimensional nature of solution scattering data results in a low information
content that limits the ability of the method to distinguish between similar structures. The
Shannon sampling theorum [37] estimates the number of independent observations, Ns as
Ns = (qmax − qmin)Dmax/pi (2.2)
which results in 15-20 data points in a typical SAXS experiment. Despite the low
amount of data, accurate solution models are able to be constructed using scattering data
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by applying empirical restraints that encourage the building of protein-like structures, such
as the use of dummy residues using the known amino acid sequence as in the program
GASBOR [38] and biasing towards globular structures utilizing bead models as emplyed
in DAMMIN [39]. The reliability of these methods are dependent on the geometry of
the shape being reconstructed, with flattened particles and cavities resulting in less stable
reconstructions than globular or cylindrical particles [40]. A particular strength of SAXS
shape reconstruction is the modelling of multimeric complexes from individual subunits
utilizing the crystallographic data from individual subunits and solution scattering from
the complex. The effect of mutations and buffer conditions on the structure and subunit
makeup of the complex can be probed using this method [41].
The introdution of third generation synchrotron radiation has allowed the collection of
scattering data at much higher resolution, called WAXS (Wide Angle X-ray Scattering).
Though WAXS data out to 1 Å or higher resolution is able to be captured, the low infor-
mation content described above makes high resolution volume reconstructions untenable.
The nature of the scattering curve, I(q), at higher resolutions, however, is extremely sen-
sitive to small perturbations in the structure of the macromolecule. Characterization of
conformational changes due to ligand binding [4244] and molecular crowding [45] have
been observed using data in the WAXS regime. Though the specific molecular interactions
involved in these changes cannot be determined, SAXS/WAXS reports changes in the entire
conformational ensemble of the macromolecular system. This, combined with the relative
ease and quickness of collecting and analyzing data makes it a powerful tool for probing
ligand induced conformational changes.
This work seeks to uncover the role of each site and binding moeity in promoting the
conformational transition of βPGM by observing changes in the solution phase structure
of the enzyme in the presence of various ligand moieties which occupy part of the active
site. The free energy of the ligand-induced conformational change for each of the two
sites is then determined using a technique recently developed by Minh and Makowski for
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calculating binding constants using solution X-ray scattering titrations [46]. Finally, the
interaction energy between the transferring and distal sites is calculated by observing the
difference in binding energy of the distal site with a moeity bound in the transferring site.
By understanding the structural outcomes and energetics of these interactions, we can gain
further insight into the mechanism by which this enzyme utilizes the prevailing theories of
ligand binding in its catalytic mechanism.
2.2 Methods
2.2.1 Protein Preparation
βPGM from Lactococcus lactis was prepared based on existing protocols [47,48]. Briefly, re-
combinant βPGM was produced from a PET3a vector obtained from the lab of Dr. Debra
Dunaway-Mariano, which was transformed into BL21(DE3) E.coli competent cells (No-
vagen). Cell cultures were induced at an OD550 of 0.6 to 0.8 with 1mM isopropyl β-D-
1-thiogalactopyranoside (IPTG) and incubated overnight at 16◦. Cells were harvested by
centrifugation and lysed with a microfluidizer in a Buffer A1. Cell lysate was centrifuged and
the supernatant run over a DEAE Sepharose anion exchange column. βPGM was eluted
using a 0-350mM gradient of NaCl in the Buffer A, resulting in 80% pure βPGM. Further
purification of the protein was acheived by ammonium sulfate precipitation, followed by
gel filtration, resulting in >95% pure βPGM by SDS gel analysis. Final samples were dia-
lyzed into a working buffer of 50-500mM HEPES pH 7.5 with 5mM MgCl2, 100mM NaCl
and 1mM DTT. Dialysis buffer was reserved for use in solution scattering studies. Sample
concentrations were measured using a nanodrop spectrophotometer at 280nm.
150mM sodium 4-2-hydroxyethyl-1-piperazineethanesulfonic acid (HEPES) pH 7.5, 100mM
sodium chloride (NaCl), 5mM magnesium chloride (MgCl2) and 1mM dithiothreitol (DTT)
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2.2.2 Preparation of Solution Scattering Samples
Recombinant βPGMwas concentrated to a stock concentration of 48mg/mL (2mM). 200mM
stock solutions of sodium metavanadate (VO3, Aldrich), sodium tungstate (WO4, Aldrich),
glucose 6-phosphate (G6P, SIGMA), β-glucose 1-phosphate (βG1P, SIGMA) and αgalactose
1-phosphate (αGal1P, Aldrich) were prepared in reserved dialysis buffer. Immediately prior
to analysis, protein stocks were centrifuged for 20 minutes at 14,000 g at 4circC to pellet any
aggregated material, however none was observed. Protein and ligand stocks were diluted
to the final working concentration of in dialysis buffer prior to analysis and placed in PCR
strip tubes (SSRL) or 96 well pCR plates (NSLS) for sample analysis.
2.2.3 Observation of ligand-induced structural changes via solution X-
ray scattering
To test the effects of ligand-protein interactions on the solution state conformation of
βPGM, the solution X-ray scattering profile of the enzyme was observed in the presence of
moeities that are known to fill all or part of the active site2. Phosphate mimics, tungstate
(WO42−) and vanadate (VO3−), have been observed to bind in the transferring phosphate
site of HAD phosphatases [49], and could potentially bind to the distal site; monophospho-
rylated glucose moieties, glucose 6-phosphate (G6P), β-glucose 1-phosphate (βG1P) and
αgalactose 1-phosphate (αGal1P) can bind with their phosphate groups bound in either
phosphate site3; while G6P and VO3− together will form a transition state analogue that
occupies the entire active site [49]. Analysis of the conformational changes due to interac-
tion with ligand was performed by Guinier analysis [35] and observation of changes in the
wide-angle scattering signatures.
2See sections 2.1-2.3 for discussion of sample preparation and solution scattering data collection
3αGal1P has been observed crystallographically to bind with its phosphate in the transferring
site
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2.2.4 Atomic Structure fit to Experimental SAXS
Crystal structures for each liganded state of β-PGM from Lactococcus lactis were fit to
each experimental SAXS profile using FoXS [50]. Modelling of the hydration layer and
adjustment for protein excluded volume were used to improve fitting. A best fit ensemble
of the fitted models was calculated using the Minimum Ensemble Search (MES) method
of Pelikan, et. al., which uses a genetic algorithm [51] to minimize a χ2 between a linear
combination of up to five computed scattering curves and experimental data [52]. Profiles
were fit in both the SAXS (0.005 < q < 0.20) and WAXS regions (0.10 < q < 0.90)
independently and together. All results utilizing data in the range of 0.2 < q < 0.35 Å−1
were similar. The range of 0.1 < q < 0.4 is reported to include data from both SAXS and
WAXS in the fitting and utilize the portions of the scattering curve with the most difference
between states. The smallest set of structures with the lowest χ2 value was chosen as the
representative ensemble.
The low information content of SAXS coupled with a large set of possible structural
states can lead to multiple conformational ensembles producing agreement with experimen-
tal data. In addition, the "correct" conformational ensemble of a macromolecular system is
more complex than can be represented in up to five static structures. The results of these
calculations cannot be interpreted as accurate quantitative measurements of the structural
ensemble, however this computed ensemble need not be perfect to infer conclusions on the
major structural states present [53].
2.2.5 Structural characterization of ligand bound states
Structural characterization of the various ligand conformational states was performed by
comparing the experimentally generated scattering curves to computationally derived scat-
tering from available crystal structures. Of the twenty-two available structures of βPGM
from Lactococcus lactis, four distinct liganded states are observed, from which a single rep-
resentative PDB structure was chosen (Table 2.1): unliganded (1ZOL), phosphoryl group
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in the transferring site (1LVH), monophosphorylated sugar with phosphate in the distal site
(1Z4N), and transition state analogue bound (1O03)4. In addition, a PDB structure (4GIB)
from the Clostridium dificile orthologue (35% indentity) is observed with phosphate bound
in both the transferring and distal sites. A representation of this conformational state using
the L. lactis amino acid sequence was produced using the threading modeller PHYRE2 [54].
Computed solution scattering curves were generated using FoXS and ensemble fits to ex-
perimental data performed using MES (section 2.1.4).
PDB ID - Chain Ligand Resolution (Å) Conf. State
1ZOL None 1.90 Open
1LVH phosphoAsp8 2.30 Open
1Z4N αGal1P 1.97 Closed
1O03 βG16P* 1.40 Closed
4GIB** 2 x PO2−4 2.27 Intermediate
Table 2.1: Table of crystal structure PDB IDs and ligand states used in solution
scattering fitting. * - glucose 1,6 bisphosphate is observed as the transition state
phosphorane adduct to Asp8. ** - Structure created by threading sequence βPGM
from L. lactis onto template structure 4GIB from C. dificile (35% identity)
2.2.6 Solution Scattering Ligand Titration Data Collection and Process-
ing
Samples were analyzed at beamline 4-2 (BL4-2) of the Stanford Synchrotron Radiation
Laboratory [55]. Protein (1mM) and matched buffer samples for each ligand concentration
(0-50 mM) were prepared with stock solutions and reserved dialysis buffer to concentrations
as described in section 2.4. Samples were held at 283K during analysis using a water-
cooled aluminum block. 30µL of sample was drawn through the sample capillary using the
automated fluid handling apparatus. For each sample, fifteen 1s exposures were recorded
on a Pilatus 300K photon detector at a distance of 0.5m, covering a range of 0.013 < q5
4In the case of the availability of multiple structures for a given ligand state, the choice of
structure had a very small effect on subsequent fitting
5q=4pisin(θ)/λ
17
< 1.23 Å−1. Image data was processed using the BL4-2 SasTool utility [55], resulting in
individual 1D scattering profiles. Scattering profiles for each sample were averaged and
outlier replicates with χ2 ≥ 2.0 removed using a MATLAB script.
2.2.7 Deconvolution of Titration Data and Calculation of Binding Ener-
gies of Ligand Moeities
Solution scattering titrations over a range of substrate concentrations were performed to
calculate the binding energy of the conformational changes observed in the ligand screen.
Assuming that a binding event is coordinated with a structural rearrangement, the equilib-
rium constant governing the conformational transition can be expressed as:
Kconf =
[Eo][S]
[EcS]
(2.3)
where Eo is the open conformation of the enzyme, S is the substrate and EcS is the
substrate bound enzyme in the closed conformation. The observed scattering signal of
a solution, I(q) with a known initial quantity of S and E is the concentration-weighted
addition of the scattering profiles of the three elements S, Eo and EcS plus a constant
background term (See equation 2.2). Performing a set of solution scattering experiments
at increasing ligand concentration results in an initial data matrix, D. The scattering
contribution of the ligand and background term can be calculated by observing the 1D
solution scattering profiles of a matched buffer solution with increasing concentration of
ligand. The molar 1D solution scattering signal for the ligand (IS(q)) and background
component (IB(q)) can be deconvoluted using singular value decomposition (SVD) with
the method described in section 2.1.6.
For the enzyme-ligand titrations, the concentrations of S, Eo and EcS in each sample
was calculated by choosing Kconf . For a chosen value of Kconf , the background, IB(q),
and ligand component, IS(q)[S] were subtracted from the raw 1D scattering data, leaving
the scattering signal for all macromolecular structural states as a function of ligand con-
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centration. SVD was then performed on this data to determine the number of significant
scattering components. In the case of only two components, these states can be modelled
as Eo and Es, for which concentrations are set. The resulting scattering reference curves,
IEo(q) and IEcS(q) can be determined as described in section 2.1.6. These calculated quan-
tities are compared to the original data, D, using least squares regression to minimize χ2,
weighted by variance to account for heteroskedasticity at different values of momentum
transfer, q.
χ2 =
q∑ (D − [IEo(q), IEcS(q)] ∗ [[Eo], [EcS]])2
σ(q)2
(2.4)
The best fit value for Kconf is determined by the minimum χ2 variable over a range of
values. Confidence intervals for the calculated Kconf values are derived using a Bayesian
weighted least-squares method. Briefly, the log likelihood of observing dataset D with given
parameter Kconf can be represented as the ratio between uncorrelated Gaussian noise, ,
and observed sample variance σ at each titration measurement, m and value of angular
momentum, q.
lnP (D|Kconf ) = −1
2
Q∑
q=1
A∑
a=1
(
m,q
σm,q
)2 (2.5)
Bayes law can be formulated by including an uninformative Gaussian prior to obtaining
the posterior probability for observing ∆Gconf = RTlnKconf given the initial dataset.
lnP (∆Gconf |D) = −1
2
Q∑
q=1
A∑
a=1
(
m,q
σm,q
)2 − 1
2000
(
∆Gconf
RT
)2 (2.6)
The probability density, P (∆Gconf |D) can be evaluated over a range of values for
∆Gconf and the cumulative density function (CDF) calculated by normalizing and then
summing the distribution over the range of ∆Gconf . The values of ∆Gconf where the CDF
equals 0.34 and 0.66 indicate -1 and +1 standard deviation values away from the point
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estimate (CDF=0.5), respectively.
2.2.8 para-Nitrophenyl Phosphatase Inhbition Assays
Reaction solutions containing 2-10 µM βPGM, 5-50 mM p-nitrophenyl phosphate (pNPP),
5 mM MgCl2 and 50 mM sodium HEPES pH 7.5 were analyzed at 410 nm and the initial
velocities analyzed in a Lineweaver-Burke plot to obtain the Km for pNPP. Determination
of the Ki for G6P and NaVO3 was done by performing the same analysis as above, in the
presence of increasing concentrations of either ligand, from 0.2 to 10 * Ki. The resulting
initial velocities with increasing concentration of pNPP were plotted and the KM,app for each
ligand concentration found. The Ki for G6P and NaVO3 was calculated using equation 2.7:
KM,app = KM (1 + [I]/Ki) (2.7)
2.3 Results and Discussion
2.3.1 Solution X-ray Scattering Characterization of βPGM Conforma-
tional States
Solution scattering data were collected on βPGM in complex with various ligand moeities
that occupy some or all of the active site. All scattering profiles were similar over the entire
resolution range 0.005 ≤ q ≤ 2.0, indicating that introduction of ligand did not unfold or
change the oligomerization state of the protein [Fig 2.1(a)]. Guinier analysis on each sample
was performed in the range of 0.9 ≤ sRg ≤ 1.3 and shows good sample homogeneity and
the absence of major aggregation or interparticle repulsion [Fig 2.1(a), Inset].
Calculation of the Guinier radius of gyration (Rg) values for the holoenzyme and each
ligand bound state are shown in Table 2.2 and show three ranges of values among the differ-
ent ligands. The holoenzyme had, predictably, the largest Rg at 18.0 ± 0.09 Å, indicating
the most extended conformational ensemble. βPGM in the presence of transition-state ana-
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logue components G6P and VO3− forms a significantly tighter complex, with an ∆Rg of
approximately 1.7 Å, consistent with a more compact particle. This difference was larger
than the difference in the geometric radius of gyration values (∆Rg=1.0 Å) calculated from
the crystal structures of the two states6. Flexible macromolecules analyzed by crystallogra-
phy and solution scattering have been observed with higher Rg values in the solution phase,
indicative of restrained motions in the crystal lattice [56, 57], which is consistent with the
current observation.
Ligand Rg (Å) ∆Rg (Å)
No Ligand 18.0 ± 0.09 
Glucose 18.0 ± 0.08 0.0
WO42− 17.0 ± 0.09 -1.0
G6P 17.4 ± 0.06 -0.6
βG1P 17.6 ± 0.06 -0.4
Gal1P 17.2 ± 0.09 -0.8
G6P + VO3− 16.3 ± 0.06 -1.7
Table 2.2: Statistics from Guinier analysis of solution scattering curves of βPGM
in complex with various ligands. Data collected at Beamline X9 with protein concen-
trations of 25mg/mL (1mM) and ligand concentration of 20mM. Guiner and Porod
analysis performed using PRIMUS [58].
Ligands which are only able to occupy part of the active site were each seen to depress Rg
by an intermediate amount, between 0.4 and 0.8 Å for the monophosphorylated sugars G6P,
G1P and Gal1P; and 1.0 Å for the phosphate analogue WO42−. Glucose is observed to have
no effect on the scattering curve or Rg. This indicates that binding linked to conformational
change in βPGM requires a phosphate moeity, and that the sugar interactions themselves
are not sufficient to induce a structural rearrangement. While both monophosphorylated
sugars and phosphate analogue are able to induce a partial closing of the enzyme, neither
are capable of filling the entire active site. This shows that neither moeity by itself is as
6Geometric Rg was calculated in MATLAB using the mass weighted position of each heavy atom,
waters excluded. PDB 1ZOL was used to represent the unliganded state while 1O03 was used for
the transition state analogue.
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proficient as the transition state analogue in stabilizing the closed, catalytically competent
complex.
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Figure 2.1: (a): Overlay of small angle X-ray scattering of βPGM in various ligand
states Inset: Guinier region (b): Pictoral representations of ligand moeities in the
active site. The transferring phosphate is at the bottom right while the distal site is
represented in the top left. The border color identifies the line color corresponding
to that ligand state in parts (a) and (c). (c): Overlay of wide angle scattering of
βPGM in various ligand states.
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2.3.2 Monophosphorylated Sugars and Phosphate Analogues Produce
Different Conformational Outcomes
Major differences in the shape of the scattering curves between liganded states of the en-
zyme were observed in the ranges of 0.2 ≤ q ≤ 0.4 Å−1, which corresponds to a nominal
resolution range of 30 to 15 Å [Figure 2.1(b)]. The holoenzyme scattering signal was rel-
atively featureless in this medium resolution range, with a small, broad well at q=0.25.
In contrast, βPGM in complex with the transition-state anologue was observed to have
two sharp features at q=0.25 Å−1 and q=0.38 Å−1. The sharper features in the bound
structure, along with the depression of the Rg are consistent with a more compact, spheroid
structure as compared to the holoenzyme, whose featureless profile is indicative of a flexible,
polydisperse structural ensemble [Fig 2.2] [41].
Figure 2.2: Effect of Polydispersity on Scattering Signal. Plot of calculated scatter-
ing from a collection of spheres with increasing polydispersity. The black line shows
calculated scattering for a monodisperse mixture of spheres with diameter 15 Å. Blue
and red lines show polydisperse mixtures, with gaussian distributions of sphere di-
ameters at σ=1 and σ=2 Å, respectively. Figure adapted from [41]. Data calculated
using MiePlot.
The scattering signal in the presence of monophosphorylated sugars αG1P7, αGal1P
7αG1P signal suffered from beam drift during sample collection, resulting in reduced scattering
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and G6P all showed similar features, with two features at q=0.25 and q=0.38 [Fig 2.2(a),
purple and orange, respectively], indicative of a partial closed structure. Indeed, a linear
combination of the open and closed structure fits very well (1.0 χ2) for αGal1P and G6P
[Table 2.3]. This intermediate signal can be interpreted as either an equilibrium between the
open and closed conformations, or a partially closed binding state. The former is the most
likely scenario, since the observed crystal structure of βPGM with αGal1P is observed
to adopt a conformation very similar to that of the transition state bound crystal (Cα
RMSD=0.7 Å), rather than a single intermediate conformation. In addition, the different
signals observed for G6P and Gal1P would implicate different binding modes for the two
sugars, which is unlikely. The linear combination interpretation leads to the conclusion that
G6P and αGal1P both are able to induce the closed form of the enzyme, and do so in the
same fashion, binding with phosphate in the distal site. Since binding of a phosphohexose to
the distal site precludes the same ligand from binding to the transferring site, this implicates
the distal phosphate site as the mediator of conformational change in βPGM.
Ligand χ2 Fraction Closed Fraction Open
WO42− 41.9 0.66 0.34
Gal1P 1.06 0.42 0.58
G6P 0.96 0.28 0.72
Table 2.3: Populations corresponding to a linear combination of unliganded (blue
in Figure 3.1(b)) and transition-state analogue bound (red) wide-angle scattering
signal in the ranges of 0.2 ≤ q ≤ 0.4.
βPGM with phosphate mimic WO42− bound is observed to have a clearly different
scattering profile, with a single feature at q=0.25 [Fig 3.3(a), aqua]. This alternate state
may be a consequence of either a single binding event in the transferring site, or binding
to both the transferring and distal phosphate sites. This interpretation is crucial to the
intensity and high signal to noise ratio. The experiment was not able to be reproduced due to loss
of ligand supply. It is shown here for its consistent results with similar ligands and is not discussed
further
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understanding of the mechanism of conformational change. A binding event in the trans-
ferring site that causes this change indicates a prearrangement mechanism, where αG16P
has an initial binding event at the transferring site, that causes the enzyme structure to
partially close. If the observed structural state is a result of binding in the distal site, this
provides further evidence of the role of the distal site as the mediator of the conformational
transition.
2.3.3 Solution scattering fit to available crystal structures of βPGM
To structurally characterize the liganded states of βPGM observed via solution X-ray scat-
tering, the experimental results were compared to computed scattering profiles from a subset
of available PDB coordinates of βPGM in complex with various ligand moeities [Figure 2.3].
The holoenzyme solution scattering fit best to the computed scattering from the holoen-
zyme crystal structure, 1ZOL, indicating that it is the best representation of the unliganded
solution state conformation of the enzyme [Figure 2.3(b)]. The χ2 value was large com-
pared to the other ensembles, suggesting that this structure does not completely represent
the open conformational ensemble of the enzyme.
Scattering from the transition state analogue G6P+VO3, fits best to a superposition of
the βG16P bound and αGal1P liganded crystal structures. These fits are slightly better
than the fits to the individual crystal structures [Fig 2.3(f)]. The difference between these
two structures is subtle, with the Gal1P structure slightly more open, as the distal site
is slightly farther away from the catalytic Asp8 in the absence of a bridging ligand at the
transferring site. The ensemble fit could be indicative of flexibility of the transition state
analogue in solution, the possibility that VO−3 does not bind fully, or slight rearrangements
of the structure due to crystal contacts. In any interpretation, however, the solution struc-
ture of the transition state ensemble is approximated by the closed state of the enzyme.
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Figure 2.3: (a): PDB backbone traces for structural models used in fitting, overlaid
by core domain. (b)-(f): Ensemble theoretical scattering fits (lines) to experimental
data (points). Ensemble components and percentages are labelled in each insert
.
Both the αGal1P and G6P experimental profiles fit best to an ensemble of the αGal1P
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liganded and unliganded structure [Fig 2.3(d,e)]. The fits are significantly better than to
either crystal structure alone. The two crystal structures have a large difference (Cα RMSD
= 2.5 Å), with that of the αGal1P structure, very similar to the closed structure. This is
consistent with the observation in the previous section that the monophosphorylated sugars
produce a structural state that approximates an equilibrium between the open and closed
forms of the enzyme. The crystal structure fits confirm that this is likely due to equilibrium
between closed enzyme (similar to the Gal1P crystal), with the ligands positioning their
phosphate in the distal site; and unliganded enzyme. This is further evidence to support
the distal site as the major contributor to the conformational shift observed in βPGM.
Experimental profiles of WO42− in complex with βPGM produce a best fit to the Asp8-
phosphorylated crystal structure and two-phosphate bound homology model derived from
the D. difficile isoform of βPGM [Figure 2.3(c)]. The phosphoAsp crystal structure is very
similar to the open structure (Cα RMSD = 1.1 Å), while the two-phosphate bound structure
has a unique conformation, with the distal site residue sidechains ordered by the phosphate
ligand, but the cap pivoted away from the active site. The computed solution scattering
profile of this two-phosphate bound structure has the single dip feature observed in the
βPGM-WO42− solution scattering data. This data fit suggests that the unique solution
scattering observed is due to a WO42− binding event in the distal site, again implicating
this low affinity interaction as crucial for stabilizing the conformational transition.
2.3.4 Conformational binding equilibria and kinetic inhibition show low
affinity distal site and high affinity transferring site
Titrations of βPGM and G6P and VO3− were performed to link conformational change
with binding and isolate the conformational effect of the two phosphate binding sites, as
well as to probe for the possibility of binding intermediate states. In both cases, the binding
events were observed as two-state, with only two major scattering components extracted
from the background and ligand subtracted scattering titration data. This observation
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does not rule out the possibility of multiple binding states, however shows that only two
significant conformational states can be resolved using this method.
Calculated binding energies for G6P, assumed to bind in the distal site, and VO3− are
both similar and low affinity, around 5.8 mM (Table 2.4), suggesting that both binding
events occur in the distal site. Vanadate binding to the high affinity trasferring site, then,
is likely to have little effect on the conformation of the enzyme. Kinetic confirmation of the
binding constants for G6P and VO3− were performed using a pNPP phosphatase inhibition
assay, as previously utilized for βPGM [18]. Approximating both Ki and the previously
calculated Kconf as Kd dissociation constants, the binding constant of G6P is found to
be in the low millimolar range using both methods, with 5.8 mM observed via solution
scattering titration and 1.5 mM via inhibition kinetics. Vanadate, however, is observed to
bind over 100 fold tighter in the kinetic assay (Ki = 0.05 mM) versus the conformational
assay (5.7 mM). The high affinity value observed via kinetics is similar to inhibition values
observed for vanadate in other phosphate binding sites such as alkaline phosphatase and
acid phosphatase8. Thus, the pNPP assay is likely observing vanadate inhibition resulting
from binding to the transferring phosphate site of the enzyme.
To see if a high affinity binding event was missed during initial analysis of the scattering
titration, the VO3− data was re-analyzed to identify three protein components with two
binding constants: one respresenting the kinetically determined transferring site (0.05 mM)
and one representing the scattering derived distal phosphate site (5.8 mM). No third macro-
molecular scattering component was able to be resolved. For the high affinity vanadate site
to be observable via solution scattering titration, binding must induce a significant confor-
mational change in the enzyme. The crystallographic evidence supports this observation,
as the phosphoAsp and holoenzyme crystal structures are nearly identical, within RMSDCα
= 1.0 Å, and likely not resolvable via solution scattering.
8Values of 0.0005 to 0.1 mM for various isoforms, from BRENDA
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Figure 2.4: (a): Raw scattering data for VO3− titration. (b): Ligand and back-
ground subtracted scattering data. (c): Calculated reference scattering components
for background (red), VO3− (green), unliganded protein (blue) and liganded protein
(purple)
.
The low affinity binding events explain the fit to multiple states observed in the solution
scattering ligand screens (Sections 2.3.1-2.3.3). At the conditions presented, 20mM ligand
and 1mM enzyme, a binding constant of 5.8 mM predicts that 23% of the enzyme will be
unliganded, and presumably in the open conformational state9. This fraction is well within
the range of observation via solution scattering and likely leads to the observation of multiple
structural states at these concentratrations. In total, these result strongly implicate a low
affinity distal phosphate site that results in a closed form of the enzyme, and a high affinity
transferring phosphate site that has little, if any, effect on the conformation of the enzyme.
9Full occupancy (>95%) of the distal site at these enzyme concentrations (required to acheive
sufficient signal to noise), would require over 100 mM substrate, concentrations where pH adjust-
ments would have to be made to the buffer, resulting in imperfect matching between protein and
sample.
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Ligand ∆Gconf (kcal/mol) Kconf (mM) Ki (mM)
G6P 2.89 ± 0.21 5.8 ± 1.8 1.5 ± 1.6
VO3− 2.90 ± 0.22 5.7 ± 1.9 0.05 ± 0.01
G6P (VO3−) -5.10 ± 0.08 0.11 ± 0.02 
Table 2.4: Calculated free energies and equilibrium constants of ligand-induced con-
formational change calculated via solution X-ray scattering titration and inhibition
constants calculated by pNPP phosphatase inhibition assay.
2.3.5 Synergistic Binding between VO3
− and G6P indicates Conforma-
tional Activation Role of Transferring Phosphate
The interactions between the transferring and non-transferring sites were probed by per-
forming solution scattering titrations of G6P in the presence of 20mM VO3−, which os-
tensibly will saturate the 0.05 mM transferring site. The binding of G6P in the presence
of a filled transferring site was nearly 100 fold tighter (Kconf=0.08mM) than G6P alone,
corresponding to a synergistic increase in binding energy of over 2 kcal/mol in relation to
G6P alone[Table 3.5]. Synergistic binding between ligand pieces are not considered to be a
result of ligand-ligand interaction, but rather a structural effect, with the first site providing
a prearrangement benefit to the second binding event; or energetic, where the first ligand
changes the energy landscape for the binding of the second [59]. The lack of a discernable
structural intermediate in the pure VO3− titration suggests that this is not a structural
effect, so this assistance must be energetic. Indeed, it has been shown that an observable
conformational change need not occur to induce allosteric activation of a biomolecule [60],
an example of which is observed in the binding of cAMP to the dimeric catabolite activator
protein, where a binding event on one monomer does not alter the conformation of the sec-
ond monomer, yet is shown to have a negatively cooperative effect on binding. Rather than
induce a new conformational state, this type of allosteric effect is accomplished by modifying
the enzyme dynamics and changing the free energy distribution between liganded and un-
liganded states. This effect in βPGM would allow the binding energy of a single phosphate
moeity in the transferring site to activate the enzyme for binding the singly phosphorylated
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sugar, without performing a partial closing transition that may preclude a binding event.
This synergistic mechanism also allows the phosphorylated enzyme to maintain a high
affinity for its binding partner, either βG1P or G6P, while dropping the affinity of these
species 100 fold for the unphosphorylated enzyme, where a binding event would preclude
productive binding of βG16P. In a cellular environment where concentrations of hexose
phosphates have been observed at 8.8 mM [61], while βG16P are typically observed at 1000
fold lower concentrations [62], this affinity regulation is crucial for preventing substrate
inhibition.
2.4 Summary and Conclusions
βPGM, as part of its substrate recognition mechanism, undergoes a large conformational
transition upon binding ligand. Solution scattering and molecular dynamics have been
utilized to investigate the specific ligand-protein interactions that govern this conformational
change, uncovering the induced-fit nature of the transition and reliance on nonreacting
substrate binding energy to drive the conformational change. The trivalent active site of
βPGM, which includes the transferring phosphate site, the sugar site and distal phosphate
site was studied by binding the enzyme to moeities able to fill all or only part of the active
site.
The effects of monophosphorylated sugars and phosphate analogues on the conforma-
tional state of the enzyme were probed by observing the solution X-ray scattering at high
concentrations of enzyme (1mM) and ligand (20mM) and comparing them to theoreti-
cal calculations from available crystal structures. The differences in scattering signal for
monophosphorylated sugars indicated an equilibrium between the open and closed con-
formation, implicating a role for the distal site in facilitating the formation of the closed
conformation. The phosphate analogue tungstate produced a unique conformational sig-
nature via solution scattering, which was found to approximate a crystal structure with
both phosphate sites bound. Taken together, these results suggest that facilitating the
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conformational change relies on occupation of the distal phosphate site.
To correlate the conformational effect of each ligand with a binding event, solution scat-
tering titrations were performed to calculate the Kconf of the monophosphorylated sugar,
G6P, and phosphate mimic vanadate, which were then compared to inhibition constants
derived from pNPP phosphatase inhibition assays for the same ligands. It was found that
the inhibition and conformational equilibrium constants for G6P were very similar, in the
low millimolar regime, while vanadate inhibited at the low micromolar level, yet induced
conformational change in the low millimolar regime. Phosphate analogue binding to trans-
fer sites has been well characterized in the low micromolar and tighter regimes, leading
to the conclusion that the kinetically determined binding constant for vanadate represents
the transferring site. Thus, the conformationally determined binding event must be at the
distal site. The observation of synergistic binding between G6P and VO3−, however, does
indicate an energetic role of transferring site occupation on the conformational transition.
The nature of this energetic effect could be a subtle altering of the conformational free
energy landscape that is not observable via solution X-ray scattering.
Attempts to isolate a conformational effect from the transferring site binding event were
unsuccessful, however, this does not rule out a conformational effect. Multiple conforma-
tional ensembles, in theory, can map to the same solution scattering curve. In this case, the
unobservable conformational shift induced by binding in the transferring site would repre-
sent an intermediate state. This would suggest a pre-arrangement mechanism, by which
occupation of the transferring site moves the conformational ensemble towards the closed
state, increasing the binding affinity for βG1P or G6P in the distal site.
These findings are consistent with the recent analyses of ligand binding systems, where
interactions between enzyme and ligand far from the active site contribute most of the
energy toward the conformational transition [63]. The 3 kcal/mol observed difference in
binding energies between the transferring and distal phosphate sites of βPGM coincides with
this theory, which derives from Jencks treatment of substrate-induced enzyme activation
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where binding energy from a distant portion of the substrate is used to drive unfavorable
conformational changes in the enzyme [24]. The binding of phosphate to a phosphate
binding site is generally a high-affinity event, with ∆G values on the order of 4-6 kcal/mol.
The ~3 kcal/mol difference in energy between a fixed phosphate binding site and the distal
phosphate site likely represents some of the amount of binding donated to stabilizing the
unfavorable conformation of the enzyme.
Figure 2.5: Synergistic binding between phosphate binding sites allows substrate
discrimination in βPGM. Top: Unphosphorylated enzyme has high affinity (50 nM)
for bisphosphorylated glucose substrate, which binds in both phosphate sites. Singly
phosphorylated glucose, which can bind in the distal site and unproductively close the
enzyme, has low (5 mM) affinity, preventing substantial inhibition from this moeity.
Bottom: Phosphorylation of the enzyme at the transferring site Asp8 is seen to have
a synergistic effect on binding at the transferring site, raising the affinity for singly
phosphorylated glucose, facilitating turnover. Bisphosphorylated glucose is unable
to bind to this form of the enzyme.
In either case, the synergistic binding represents a substrate gating mechanism, by
which βPGM is able to tune its substrate binding profile based on the phosphorylation
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state of Asp8. In the unphosphorylated form of the enzyme, the unproductive binding of
monophosphorylated sugars in the distal site is disfavored, reducing any substrate inhibition
effects on productive βG16P binding. The subsequent phosphorylation at Asp8 following
βG16P binding then shifts the enzyme's affinity towards G6P and βG1P. In this way, the
enzyme is able to maintain high fidelity for the correct substrate moeity based on its own
activation state.
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Chapter 3
Conformational Effects of β Phosphoglucomutase Liganded
States
3.1 Introduction
In Chapter 2, the role of the distal phosphate site and catalytic transferring phosphate site
in promoting the conformational transition of βPGM was discussed, with the finding that
the distal site far from the catalytic site is the mediator of the conformational transition.
Analysis in Chapter 2 relied on X-ray crystallographic structure determination, which pro-
vides static atomic-resolution snapshots of structural states, and solution X-ray scattering,
which provides a low resolution ensemble view of structural rearrangements in the solution
state. A lingering question is the conformational effects of filling the transferring site with
a phosphate or phosphate analogue. Although solution scattering was not able to resolve
a major change in the conformational equilibrium, the ~1.5 kcal/mol of synergistic binding
energy between vanadate and glucose 6-phosphate binding observed in Chapter 2 implies
that occupation of the transferring site does alter the free energy landscape of the enzyme
conformational transition. The microscopic features of these binding events cannot be dis-
cerned through static crystal structures or the low resolution of solution X-ray scattering.
Molecular dynamics, used judiciously, can provide the atomic resolution and solution phase
equilibrium sampling required to answer these questions more fully.
Equilibrium molecular dynamics is based on the assumptions that atomic motions can
be calculated with classical mechanics and that the forces that drive these motions can be
obtained from a single energy function. These assumptions reduce the dynamic modeling of
molecules to the integration of Newton's equations of motion. The simple equality F=ma
used in classical mechanics is employed at the molecular level by defining a parameter-
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based empirical force field to describe the complex energy functions derived from quantum
mechanics. This work utilizes the CHARMM force field, which uses the potential energy
function:
UCHARMM = Ubond + UBorn + Uangle + UUB + Udih + Uimp + UCMAP + ULJ + Uelec (3.1)
where Ubond describes the sum of the potential energy of each chemical bond. The
energy of an individual bond between two atoms is described as a spring function based on
the bond length r, with force constant Kb, and equilibrium bond length r0 each standard
for a specific atom pair.
Ubond =
∑
bonds[Kb(r − r0)2] (3.2)
Uangle is the sum of potential energies over all three atom center angles in the macro-
molecule, also approximated as a spring function with force constant Kθ, and equilibrium
angle θ0 parameters for each unique angle.
Uangle =
∑
angles[Kθ(θ − θ0)2] (3.3)
Urea-Bradley interactions, UUB, describe a harmonic interaction between atoms sepa-
rated by two chemical bonds (1-3 interactions), and are included for certain atomic pairs [?].
UUB =
∑
UB[KUB(rUB − rUB,0)2] (3.4)
The potential of an individual dihedral angle, ψ is modelled as a sum of periodic func-
tions with period n and angular offset δ. The total Udih is the sum of the potential over all
dihedral angles.
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Udih =
∑
dih[
∑
NKψ((1 + cos(nψ − δ))] (3.5)
Improper dihedrals are modelled as a harmonic spring:
Uimp =
∑
imp[Kω(ω − ω0)2] (3.6)
The CMAP correction is used to improve the conformational properties of the backbone
dihedrals. It is utilized as a cross-term based on the Φ and Ψ angles of a residue
UCMAP =
∑
residues[Ψ,Φ] (3.7)
ULJ is the Lennard-Jones potential that approximates Van-der-Waals forces between
atoms, where rij is the distance between particles i and j, rm,ij is the potential minimum
and ij is the depth of the potential well.
ULJ =
∑
i=1
N
∑
j = i
N [ij [(
rm,ij
rij
)12 − 2(rm,ij
rij
)6]] (3.8)
Finally, the electrostatic potential is determined as the sum of the pairwise electrostatic
interactions between each pair of atoms as calculated by Coulumb's Law, where qi qnd qj
are the partial charges on atom centers i and j,  is the dielectric constant and rij is the
distance between the atomic centers.
ULJ =
∑
i=1
N
∑
j = i
N [
qiqj
rij
] (3.9)
Subsequent to evaluation of the force at a certain configuration of the molecular system,
the acceleration of each atom center can be determined and the position of that atom after a
particular timestep, generally chosen to be on the order of a bond vibration (1-4 fs), can be
determined [Equation 3.2]. After movement of all atoms, the system force can be evaluated
again and propagated for a number of timesteps, N , indefinitely. As N approaches infinity,
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the system, theoretically, should sample all possible configurational states.
Various algorithms have been developed to propagate the system forward in time. Each
method, however, represents the by position r and velocity v of the system at time t + δt
as truncated Taylor series:
r(t+ δt) = r(t) + v(t)δt+
1
2
a(t)δt2v(t+ δt) = v(t) + a(t)δt+
1
2
b(t)δt2 (3.10)
The most straightforawrd algorithm sums the Taylor expansion of the position propa-
gated forward and backwards by δt
r(t+ δt) = r(t) + v(t)δt+
1
2
a(t)δt2r(t− δt) = r(t)− v(t)δt+ 1
2
a(t)δt2 (3.11)
resulting in the Verlet algorithm:
r(t+ δt) = 2r(t)− r(t− δt) + a(t)δt2 (3.12)
This method requires only the previous positions and computed acceleration to prop-
agate the system, however this algorithm has low precision. A more accurate method,
the Leap-frog algorithm, first evaluates the velocities at t + 1/2δt before determining the
positions at t+ δt.
r(t+ δt) = r(t) + v(t+
1
2
δt)δtv(t+
1
2
δt) = v(t+
1
2
δt) + a(t)δt (3.13)
The major drawback to equilibrium dynamics simulation is the computational cost re-
quired to evaluate the individual atomic forces at each timestep, especially for a large num-
ber of atomic centers, n. The pairwise nature of the electrostatics evaluation results in force
calculation times scaling at O(n2), making systems of thousands of atoms prohibitively ex-
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pensive to analyze to full equilibrium. While certain strategies to reduce computational load
such as electrostatic cutoffs, continuum solvation models and fixed bond lengths are rou-
tinely employed, the accessible timescale of equilibrium simulations remain short compared
to the structural events of interest in protein dynamics. Currently, equilibrium simulations
have been propagated into the millisecond regime [64] over a number of weeks using special-
ized hardware. Since typical domain-level configurational rearrangements in proteins are
on this timescale, multiple simulations of this length are necessary to sample the multiple
transitions required to fully characterize the conformational equilibrium.
To quantify conformational free energy changes in a macromolecular system, a reduced
parameter method is utilized to focus data collection on the conformationally interesting
aspects of the system. This reduction can be accomplished by calculating the free-energy
landscape, or potential of mean force (PMF), over a carefully chosen set of coordinates
that describe the transition of interest. This parameter, sometimes referred to as a reaction
coordinate, can take the form of a geometric quantity, such as a distance beteween two
atoms or sets of atoms; a dihedral angle or RMSD from a target coordinate set. Linear
combinations of these quantities can be used as well.
The energy functions at the heart of molecular dynamics simulations are based in first
principles, however the non-treatment of polarizability, among other approximations, can
lead to nonphysical results. In addition, the sheer volume and atomic precision of structural
data resulting from long MD studies can lead to overinterpretation of results. Thus, care
must be taken to correlate quantities derived from computational studies to experimen-
tal values. In the case of βPGM, the conformational ensembles that are the focus of this
study are analogous to the conformational ensembles that are observed during a solution
X-ray scattering experiment. Solution X-ray scattering observes millions of particles over a
timespan of seconds, such that structural data from the entire conformational ensemble for
the particular state is observed in one experiment. Theoretically, the computed scattering
pattern of the protein structures derived from MD experiments in a weighted average with
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their statistical probability determined from free energy simulations should fit to the exper-
imental solution scattering curve. This method has been used to validate MD simulations
in other large macromolecular systems [41,65].
This study utilizes both all-atom equilibrium and umbrella sampling free energy calcu-
lations to study the individual binding site contributions to the conformational equilibrium
of βPGM. Equilibrium simulations are used to study the stability of the catalytically com-
petent, closed crystal structure in the presence and absence of various ligand fragments,
as well as to define suitable conformational parameters for use in umbrella sampling. The
closed state of the enzyme is found to be unstable when the distal phosphate site is not
occupied, progressing spontaneously to an open conformational state within nanoseconds.
In addition, the unliganded state is observed to adopt a more open conformation than
observed in the crystal structure. Two cartesian principal components are derived from
the equilibrium simulations that delineate the two conformational states. Calculated PMF
maps show the unliganded enzyme has a broad energy well in the open conformation with
two shallow metastable states, with a 6 kcal/mol barrier separating it from the closed con-
formation. The βG16P bound enzyme has a 18 kcal/mol driving force towards the closed
state. conformation. Structures obtained from the conformational wells determined via
umbrella sampling show excellent agreement with experimental solution X-ray scattering
profiles.
3.2 Methods
3.2.1 Equilibrium Molecular Dynamics
All-atom molecular dynamics simulations systems were constructed from the crystal coordi-
nates of the intermediate bound βPGM (1O03) in the closed conformation and the βPGM
holoenzyme (1ZOL) representing the open state. Liganded systems were constructed in the
1O03 template by removing atoms from the intermediate and replacing them with water.
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For example, to represent glucose 6-phosphate, the atoms of the phosphorane, PO2−3 , bridg-
ing the C1 hydroxyl and carboxyl of Asp8 were removed and three waters placed at the
positions of the deleted oxygen atoms. Crystallographic waters were also included in the
model building, which was performed using CHARMM [66].
CHARMM27 force field compatible parameters for β-glucose 1,6 bisphosphate, β-glucose
1-phosphate and β-glucose 6-phosphate were constructed by creating patch residues for the
β-glucose (BGLC) scaffold from the CHARMM35 sugar parameter set [67]. Mono- and
di-anionic C6 phosphate patch residues (6P1, 6P2) were constructed by analogy from pa-
rameters and partial charges of the mono- and di-anionic 5'-phosphate-methyl tetrahydro-
furan (T5PH) from the CGenFF force field parameter set [68]. Mono- and di-anionic C1
phosphate patches were derived from the PH-B and DPH-B patch residues contained in
the CHARMM36 carbohydrate parameter set [69]. See Appendix 1 for a list of derived
parameters.
Crystal structures were minimized for 50 steps of steepest descent followed by 200 steps
of Adapted Basis Netwon Raphson with backbone atoms fixed to relax high-energy contacts.
Systems were then solvated in a TIP3P water box, with 12 Å clearance allowed on all sides
of the protein, resulting in a cubic box size of 84-86 Å. Ions were added by removing
certain water residues and replacing with K+ and Cl− ions to acheive neutrality and a final
ionic strength of 150mM to simulate the ion concentration utilized in solution scattering
studies. Solvated and minimized structures were initiated in NAMD [70] using Langevin
dynamics with a damping coefficient of 1.0 and nonbonded interaction cutoffs at 12.0 Å
with a switching function employed to 10 Å and a 2 fs timestep. The system was heated 1
K every 10 steps to a final temperature of 300 K and maintained at the target temperature
using a Berendsen thermostat [71] at constant pressure. During heating and an initial 500ps
equilibration a 10.0 kcal/mol harmonic restraint placed on the position of the Cα atoms and
the system equilibrated for 1 ns to allow for solvent relaxation around the protein system.
The resulting trajectories were analyzed for stability of the structure and ligand-active site
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interactions. Stable systems were then run using ACEMD [72], on a GeForce GTX 480
graphics processing unit for a minimum of 100 ns. The nonbonded cutoff was reduced to
9 Å and 7.5 Å for computational efficiency and the timestep increased to 4 fs. A 4 ns to
20 ns equilibration was performed while slowly reducing harmonic position restraints on
the Cα atoms from 10.0 kcal/mol to 0 kcal/mol. Equilibration of the macromolecule in the
NPT ensemble was determined by stabilization of the system energy, box dimension, and
backbone RMSD [See Appendix 2]. After equilibration, the cube dimension was fixed to an
average of the value over the final nanosecond of equilibration and the Langevin coefficient
reduced to 0.1 for production runs in the NVT ensemble.
3.2.2 Principal Component Analysis
Principal component analysis (PCA) was used to reduce the dimensionality of the motion
described in the generated MD trajectories and identify the major modes of motion between
the cap and core domains. Cartesian PCA was performed on a concatenation of the Cα coor-
dinate trajectories from the last 50 ns of all seven simulation systems, with snapshots taken
every 10 ps for a total of 35000 coordinate sets. Rotations and translations were removed by
performing a mass-weighted RMSD fit to the average structure using CARMA [73]. Calcu-
lation of cartesian principal components requires diagonalization of the variance-covariance
matrix of the atomic fluctuations, resulting in a set of eigenvectors, each representing an
independent mode of motion, and eigenvalues, which quantify the magnitude of each mode
in the analyzed trajectory. The covariance matrix, σi,j is defined as
σi,j =< (xi− < xi >)(xj− < xj >) > (3.14)
with i, j representing the 3N independent cartesian coordinates for all N heavy atoms.
Diagonalization of this matrix yields 3N eigenvectors and their corresponding eigenvalues.
The first three principal components comprising interdomain motions between the cap and
core were determined by visual analysis. PCA calculations were performed using CARMA
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[73].
3.2.3 Free Energy Surface Calculations
The free-energy surfaces of the various ligand states of βPGM were calculated along the first
two PC vectors using umbrella sampling. Initial structures were generated by performing
targeted molecular dynamics initiated from the end of the previously generated equilibrium
simulations. Conformations were positioned 2 PC units apart spanning a region from -
59:49 in PC1 space and -29:29 in PC2 space, resulting in 1484 sampling windows. Harmonic
biasing potentials of 1.0 kcal/PC unit were enforced on both components and each sampling
window allowed to relax for 60ps. A 100ps production run followed, with samples of PC
taken every 10 fs, resulting in a total of 10000 observations of the PC positions for each
sampling window. A total of 150 ns of sampling was performed for each PMF generated.
Umbrella sampling was performed in NAMD with biasing potentials enforced using the
collective variable (colvar) module.
The PMF is the potential function W (ζ) that gives the average force < F (ζ) > over all
configurations of a given order parameter: ζ [74].
W (ζ) = W (ζ∗)− kBT ln[ < ρ(ζ) >
< ρ(ζ∗) > ] (3.15)
where W (ζ∗) and < ρ(ζ∗) > are arbitrary reference values, while < ρ(ζ) > is the
average distribution function along coordinate ζ, obtained by calculating the Boltzmann
weighted average
< ρ(ζ) >=
∫
δ(ζ ′(q)− ζ)e−V (q)/kBTdq∫
e−V (q)/kBTdq
(3.16)
where δ(ζ ′(q) − ζ) is the Dirac delta function for the specific value of coordinate ζ
and V (q) is the potential at a given system configuration, q. For systems where transition
potential barriers of V (q) > kBT exist, conventional sampling techniques are not able to
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sample these conformational shifts. In these cases, enhanced sampling techniques must be
employed.
Umbrella sampling adds a coordinate-dependent biasing potential to the potential en-
ergy surface to allow sampling of high-energy states [75]. Generally, this added potential is
a harmonic function, such that the new energy potential, V ′(ζ) is
V ′i (ζ) = V (ζ) + ki(ζ − ζ0,i)2 (3.17)
where W (ζ) is the original potential along coordinate, ζ0,i is a reference position along
coordinate ζ, and ki is the harmonic force constant for window i. The resulting distribution
will be nominally centered around ζ0,i, and the distribution function, < ρ′i(ζ) >, for this
modified potential can be calculated as in equation 4.2. This distribution is non-Boltzmann,
however by sampling over a range of values for ζ0 that spans the entire desired range of ζ,
the original potential, by linking each of the Nw probability distributions by solving the set
of equations for the weighted histogram analysis method (WHAM) [76].
ρ(ζ) =
∑Nw
( i = 1)niρ
′
i(ζ)∑Nw
( j = 1)nje
V ′j (ζ)/kBT−Fj
(3.18)
eVi/kBT =
∫
eV
′
i (ζ)/kBTρ(ζ)dζ (3.19)
where ρ(ζ) is the unbiased distribution function, ni is the number of observations in
window i, used in computing the biased distribution function < ρ′i(ζ) >. Overlapping
regions of potential are fit by adding force constant, Fi to each window, resulting in a self-
consistent calculation of the free-energy potential. This calculation is easily extended into
multidimensional cases, however at considerable computational cost. WHAM calculations
were calculated using code from the Grossfueld group [77].
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3.3 Results and Discussion
3.3.1 Equilibrium Molecular Dynamics Characterization of Ligand Bind-
ing States of βPGM
MD simulations were initiated for seven distinct systems representing different liganded
states of the enzyme: unliganded; methyl phosphate (mPho) in the transferring site; βG1P
with its phosphate in the transferring site; mPho in the distal site; G6P with its phos-
phate in the distal site; and βG16P, which fills all parts of the active site. All simulations
reached RMSD and energetic equilibrium within 50 ns with no major intradomain struc-
tural rearrangements [See Appendix 2]. Calculated B-factors for the unliganded and βG16P
bound systems correlate well with experimental B-factors from X-ray crystallographic anal-
ysis [Figure 3.1(b)]. All areas where experimental B-factors are much smaller than those
calculated from MD simulation are observed as crystal contacts.
Analysis of the individual simulations highlights key differences in the conformational
outcome of filling the distal and transferring phosphate sites. Progress of changes in the
enzyme conformations were charted using the distance between the the centers of mass of
the cap and core domains of the enzyme (CCMWPd). The closed crystal structure, from
which the simulations were intiated has a value of 24.4 Å, while the unliganded crystal
structure has a value of 28.0 Å [Figure 3.1(d)].
46
(a)
(b)
0 20 40 60 80 100 120 140 160 180 200 220
0
0.5
1
1.5
2
2.5
Residue Number
R
M
S
F
(A
)
experimental B−factors
MD simulation
0 20 40 60 80 100 120 140 160 180 200 220
0
0.5
1
1.5
2
2.5
Residue Number
R
M
S
F
(A
)
experimental B−factors
MD simulation
(c)
24
25
26
27
28
29
30
31
32
33
34
35
0 10 20 30 40 50 60 70 80 90 100
C
a
p
a
n
d
C
o
re
D
o
m
a
in
s
C
O
M
D
is
ta
n
c
e
(A
)
Time (ns)
No Ligand - Open
No Ligand - Closed
mPho - Trans
G1P
mPho - Dist
G6P
G16P
Figure 3.1: (a): Pictoral representations of ligand moieties used in equilibrium
MD simulations, showing the parts of the active site filled. In each picture, the
transferring phosphate site is at the bottom and the distal site is at the top. (b):
Comparison of MD computed RMSF and experimental RMSF values from X-ray
crystallography for the unliganded (1ZOL, top) and βG16P bound (1O03, bottom)
simulations. Red background areas depict the cap domain, while blue respresents the
core. Green portions highlight residues involved in coordination of the transferring
phosphate (c): Plot of distance between mass-weighted centers of the cap and core
domain (CCMWPd) vs. time for MD simulations for each ligand. The blue and red
horizontal lines depict the CCMWPd value for the unliganded and liganded crystal
structures, respectively
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Systems originating from the closed state, with moeities that occupied the distal site
were not observed to open significantly during the simulation timeframe. βG16P and G6P
provide stabilization for the closed state of the enzyme, with an average CCMWPd of 25.9
and 25.5 , respectively, over the final 50 ns of simulation [Figure 3.1(d), red, orange].
βPGM with only a mPho moeity in the distal site was briefly observed to remain in the
closed conformation, however after 10 ns, the mPho ligand dissociated from the enzyme,
which was immediately followed by transition into an open state (<CCMWPd> = 30.5)
[Figure 3.1(d), pink]. A subsequent simulation was initiated, placing a small harmonic
restraint to keep the mPho in the distal site1, which was then observed to remain in the
closed state over the entirety of the simulation (<CCMWPd> = 20.2).
Systems without a phosphate moiety in the distal site were observed to open within the
first 10ns of unbiased production simulation. The system with no ligand equilibrated with
an average CCMWPd of 30.8 Å[Figure 3.1(d), blue], while the systems with mPho and
βG1P in the transferring site showed a slightly lowed average CCMWPd at 29.7 and 28.5
respectively [Figure 3.1(d), light blue, olive]. The instability of the closed conformation
could possibly be due to high-energy clashes resulting from poor system construction or
inadequate equilibration, that push the configuration to a non-physical state. To guard
against this, simulations were repeated, with four additional systems constructed for the
unliganded complex and two for the mPho and βG1P systems, varying the position of
the individual water molecules in the active site and lengthening the equilibration time
with protein positional restraints. All systems were found to behave similarly, with a
conformational transition to the open conformation within 20 ns.
These results clearly implicate the distal site in stabilizing the closed form of the enzyme.
The transition to the open state of the systems without a distal phosphate is in agreement
with the solution scattering observations of chapter 2, which show no significant structural
differences between the transferring site bound and unliganded enzyme conformation.
11.0 kcal/mol harmonic bias between the phosphate of mPho and CZ atom of Arg49 in the cap
domain
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3.3.2 Occupation of Transferring Site does not Prearrange Distal Site
One possibility to explain the conformational synergistic effect of transferring site binding
observed in Chapter 2 is subtle prearrangement of the distal site, which would facilitate bind-
ing of the complementary ligand. The distal site is composed of two phosphate-coordinating
functional groups, the carboxamide of Asn118 in the core domain and the guanidium group
of Arg49 in the cap. As the complex opens, these two functional groups move apart, be-
coming disordered in the open conformation. The distance distribution between the CZ
atom at the center of the guanidium group of Arg49 and the Cδ at the center of the Asn118
carboxamide was compared in the last 50ns for each simulation [Table 3.2]. The distance
distribution between these groups in the βG16P bound MD system and closed crystal struc-
ture are similar, at 5.0 ± 0.2 and 5.5 Å, respectively. The unliganded simulations (12.4 ±
2.7 Å) and both the methyl phosphate and βG1P systems with a moeity bound in the
transferring phosphate site (12.4 ± 3.4 and 11.3 ± 1.2 Å, respectively) were observed to
have a significantly larger distance between the two groups, indicating that the transferring
site is disordered. The similar distance between these values indicates that distal site ar-
rangement is not significantly affected by the presence of ligand in the transferring or sugar
site.
System Distance (Å) ± 1σ
Unliganded 12.4 ± 2.7
mPho - Trans 12.4 ± 3.4
βG1P 11.3 ± 1.2
βG16P 5.0 ± 0.2
Closed Xtal 5.5
Open Xtal 8.8
Table 3.1: Average and ± 1σ distances ( between central carbon atoms of the
guanidium group of Arg49 and the carboxamide of Asn118, which comprise the
phosphate binding moeities of the distal site.
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3.3.3 Principal Component Motions Identify Transferring Site Bound
Structural Substates
Cartesian principal components analysis of the Cα positions was perfomed to further an-
alyze the conformational outcomes of the presence of various ligand moieties, as well as
determine conformational coordinates for the system that would be reasonable for use in
free-energy simulations. Because of the rigid body behavior of the cap and core domains [34],
components describing interdomain motions were prioritized. Motions were calculated from
a concatenation of the final 50 ns of equilibrium simulation from all systems. The most
significant three motions comprise 85% of the motions of the system and 95% of the ob-
served motion between the centers of mass of the cap and core domains. Of these three
components, the first two represent motions that bring the cap and core domains together.
The third largest component defines a twisting motion along the plane separating the two
domains. All further components represent small interdomain fluctuations that are not
considered.
The largest principal component, PC1, shows a closing motion in the positive direction
that brings the lip of the cap domain, found between helices 2 and 3, toward the top of
the core domain in a motion that hinges in the previously described linker region [Figure
3.2(a)]. This motion brings together the two residues of the distal site, Arg49 and Asn118
into a position that, at PCA values greater than 30, would allow connection with a bridging
phosphate group. PC2 shows an orthogonal motion along the enzyme hinge that pivots the
cap domain the active site[Fig 3.2(b)]. The third major component comprises a side-to-side
swivel of the cap domain, similar to a head shaking no [Fig 3.2(c)].
Plotting the magnitude of PC1 and PC2 for all simulations shows a clear separation
of conformational states along the first PC axis, which represents the hinge motion of the
enzyme [Fig 3.3]. The unliganded system (dark blue) shows a great degree of flexibility
along PC1, ranging from -60 to 0 in nominal PCA units, while the two systems in the
closed state, βG16P and G6P, show a very small range of motion, between 25 and 38
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(a) (b)
(c)
Figure 3.2: Vector representation of major cap-core principal component motions
of βPGM Cα atoms. (a): PC1 (b): PC2 and (c): PC3. Vectors are plotted using an
RMSD fitted core domain, to highlight the relative motion between the two domains.
Arrow direction is in positive PCA units. Plots generated using VMD
PCA units. Both major conformational states have similar basins for PC2, however the
open conformation again shows considerably more flexibility along this axis. The increased
flexibility along both PC1 and PC2 for the open conformation correlates with the solution
scattering observation of dramatically increased flexibility in this state.
In Figure 3.3, unique structural substates are distinguished along PC1 and PC2 for
the βG1P and transferring mPho bound systems that differ from the unliganded ensemble.
Both exhibit significantly decreased average values and ranges along both PCs, showing
that both of these states are considerably less open and less flexible than the unliganded
system. However, they do not overlap with the closed ensemble. It is clear that occupancy
of only the transferring site is not sufficient to cause the full conformational transition, but
it appears that some portion of the domain-domain motion results from this binding event.
The transferring site phosphate is coordinated by the sidechain carbonyl of Asp10, which
forms a hydrogen-bond with Thr16. Thr 16, along with Asp15 are part of the linker region
between the two domains and have the largest backbone dihedral shift between the open and
closed states [34]. Binding to the transferring phosphate site may propagate interactions
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through these residues to induce subtle changes in the enzyme conformation.
Figure 3.3: Map of equilibrium simulations plotted against PC1 and PC2, colored
by ligand state. Blue - Unliganded; pink - mPho in transferring site; light blue -
mPho in distal site; olive - βG1P; orange - G6P; red - βG16P
In addition, the presence of the sugar ring provides a larger push towards the closed
confromation in PC1 and PC2. Significantly, the range along PC2 for the βG1P system
is similar to that of the closed conformation, indicating that the final binding of the distal
site is a movement along PC1, the main closing direction of the enzyme. The sugar site
significantly influences the conformation, which is notable since no hydrogen-bonding inter-
actions are observed between the sugar and protein residues. The ring-stacking interaction
between His20 and the sugar may be the source of this, as this interaction is conserved
through the entirety of the simulation.
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3.3.4 Free Energy Landscapes of βPGM Ligand States
Free energy landscapes along the first and second PC vectors were generated to describe
the conformational equilibria of both the full ligand bound and unliganded enzyme states.
The choice of PC vector order parameters is somewhat arbitrary, and neglects certain small
motions such as dihedral rotations that may affect the free energy surface []. In the case of
calculating kinetic rates of conformational change, the choice of order parameter is a critical
and challenging step. For the analysis performed here, where large structural changes are
compared to shape determinations from solution X-ray scattering, the large-scale motions
described by principal components are likely to be sufficient.
The PMF for the unliganded system [Fig 3.4(a)] shows a broad, shallow well, spanning
a large range of conformational space in both PC1 and PC2, similar to that observed in the
equilibrium simulations. Two conformational states are observed in the open conformation,
one, representing a very open conformation in the (-37,15) range and more closed conforma-
tion, in the area of (-9,-3) with 1 kcal/mol higher energy. This conformational ensemble is
similar in range to the one observed in equilibrium simulations (Figure 3.3, dark blue). The
more closed of the two conformational states is very similar to the equilibrium conformation
observed with methyl phosphate in the transferring phosphate site (Figure 3.3, light blue),
which indicates that filling of the transferring site shifts the conformational equilibrium
of the open system towards the closed state. The area of PC space corresponding to the
closed conformation, (29,-3) has no basin and is approximately 4.5 kcal/mol higher than the
open conformational energy minimum. This free energy landscape suggests that the closed
conformation is not stable without ligand present, which is consistent with the observation
of this system spontaneously opening.
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Figure 3.4: Free energy profiles (kcal/mol) calculated from umbrella sampling along
PC1 and PC2 for (a): unliganded βPGM (b): βPGM in complex with G16P. White
Xs represent local minima in the free energy surface.
The PMF calculated for the βG16P bound enzyme [Fig 3.4(b)] shows a very deep valley
in the closed conformation, also in agreement with equilibrium simulations. A 20 kcal/mol
energy barrier exists between the closed well and the more closed of the metastable open
states. The deep well observed for this state indcates high stability and lack of flexibility
of the closed state, which is in agreement with solution scattering observations and the
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equilibrium simulations.
3.3.5 Comparison of Free Energy MD Conformational Ensembles with
Solution X-ray Scattering
Comparison of the free energy MD derived conformational ensemble to experimental solu-
tion X-ray scattering results were performed by calculating the theoretical scattering profile,
as described in section 2.1.4, for structures corresponding to each point in PC1/PC2 space.
The scattering profiles were then combined in a weighted average based on the probability
distribution generated from the calculated free energy surfaces, with structural states with a
probability less than 0.01% at 298K excluded. The free energy computed scattering profile
was then compared to the experimental profile.
Solution scattering generated from the unliganded PMF compared very favorably to
experiment, with a χ2 of 0.96 [Figure 3.5(a)] which is significantly better than the calcu-
lated best fit from the set of available crystal structures, with a χ2 of 1.56 [Figure 2.3].
This observation confirms that the calculated free energy surface produces a reasonable
conformational ensemble to account for the experimental solution scattering data. The
poorer fit of the single crystal structure to the experimental data also highlights the use of
conformational sampling to improve solution scattering fits for flexible systems.
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(a) No Ligand
(b) βG16P
Figure 3.5: Comparison of experimental solution scattering profiles (red dots) to
computed scattering curves from MD ensembles (blue lines) computed with (a):
unliganded βPGM compared to unliganded solution scattering and (b): βPGM in
complex with G16P compared to solution scattering of βPGM complexed with G6P
and VO3−.
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The fit from the closed ensemble was also good, with a χ2 of 1.34 [Figure 3.5(a)]. Al-
though worse than the fit from crystal structures at χ2=1.01 [Figure 2.3], this experimental
data fits the closed MD ensemble much more closely than the open MD ensemble. Notably,
the experimental scattering data was collected with G6P + VO3− transition state analogue,
which does not contain a covalent connection between the sugar and transferring phosphate
site, unlike the G16P ligand utilized in computation of the free energy profile. The crystal
structure fit included two crystal forms, with one being the completely closed enzyme and
the other being slightly more in the open state. The better fit of these crystal structures
than the computed free energy profile to experiment may result from increased flexibility
of the enzyme without direct connection between the sugar and transferring phosphate.
3.4 Summary and Conclusions
Equilibrium and free energy molecular dynamics simulations have been used to conforma-
tionally characterize the ligand binding states of βPGM, showing significant effects from
each of the transferring phosphate, sugar and distal phosphate binding sites. Equilibrium
simulations show the instability of the closed structure in the absence of a distal phosphate
binding moeity, confirming its major effect on stabilizing the closed state of the enzyme.
The full ligand, βG16P and G6P are observed to stabilize the closed form of the system,
while the systems without a distal phosphate are observed to spontaneously open. Free
energy simulations confirm the conformational ensembles observed for the unliganded and
βG16P equilibrium simulations are reasonable, and correlate well with solution scattering
experimental observation.
Occupation of the transferring site had been observed using solution scattering titrations
to promote distal site binding by nearly 2 kcal/mol. Though not observed during solution
scattering experiments, equilibrium simulations show that occupation of the transferring
site reduces the motions of the cap domain and keep it closer to the closed conformation.
Though transferring-site binding does not directly assist in arranging the distal site residues
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for binding, the reduction of the cap-core dynamics will reduce the negative effects of
the entropy loss involved in the transition from the flexible open state to the rigid closed
ensemble. The mechanism of how a phosphate or phosphate analogue in the transferring
site facilitates the conformational change is unknown, but its proximity to the hinge region
of Asp15-Thr16 suggest that it may assist in lowering the energy of reconfiguration of these
dihedral angles. This is an interesting avenue for futher study.
The effect of the sugar moeity in stabilizing the closed structures is of interest, since
no direct connections are observed between the sugar residue and the protein. However in
both the distal and transferring phosphate examples, addition of the sugar group promoted
further stability in the cap-core system. A ring stacking interaction with His20 may account
for this stabilization, and the presence of this residue may help select for a ligand scaffold
based on a sugar moeity.
Overall, the conformational effects observed from each of the ligand moeities indicate a
possible cooperative binding mechanism among all three sites, with the high-affinity trans-
ferring site binding the ligand first, which helps to reduce the conformational flexibility
of the cap-core system and promote binding to the distal site, which stabilizes the closed
complex of the enzyme.
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Chapter 4
Sequential Steps in Forming βPGM Catalytic Complex
4.1 Introduction
The diversification of enzymatic catalysis has long been implicated in the proliferation of
higher organisms. To produce and break down the multitude of complex molecules needed
to sustain life, the enzymes that catalyze these reactions, in addition to providing a suitable
catalytic platform, must have a certain binding affinity for the substrate molecule, which
may have a very low physiological concentration. The selection of an active site for binding
a certain moeity can be achieved by shape and electrostatic complementarity, among other
methods [78]. By regulating the type of moeity that can bind to its active site, an enzyme
achieves a certain activity profile. Surprisingly, or perhaps not, the scope of enzymatic
activity in almost completely described by a small set of protein scaffolds; the enzymatic
superfamilies [79]. Within these superfamilies, structure of the active sites and mechanistic
aspects of the chemical step are, for the most part, conserved. Thus, it is the evolution of
novel substrate specificity mechanisms that has allowed the broad diversification of enzyme
function [32].
Despite the varied evolution of phosphate transfer activities, the phenomena of phospho-
mutases are relatively rare. Mutase mechanisms have evolved in numerous superfamilies
of phosphate transfer, utilizing established catalytic machinery to perform mutase func-
tion. These mechanisms proceed via different phospho-amino acid intermediates, namely
phospho-Ser (phosphohexomutase and alkaline phosphatase superfamilies), phospho-His
(histidine phosphatase and acid phosphatase superfamilies), and phospho-Asp (HADSF).
The major differences between these intermediates are the relative stability of the phospho-
rylated adducts, with phospho-Ser being extremely stable [6].
α-Phosphoglucomutases (αPGM), members of the phosphohexomutase superfamily, cat-
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alyze phosphoryl transfer utilizing an ATP-activated phosphoserine intermediate, an ex-
tremely stable phosphate linkage [80]. The stability of this moeity allows kinases of this
superfamily to keep their active sites solvent-exposed while awaiting a substrate binding
event. In the case of αPGM, this ensures that the charged phospho-serine will not be
hydrolyzed while the substrate is reorienting in the active site.
The evolution of phosphomutase activity from a scaffold utilizing unstable phosphory-
lated residues pHis and pAsp has occurred in the HAD and histidine-phosphatase superfam-
ilies. The use of the relatively unstable phosphorylated residues allows efficient recycling of
the active, unphosphorylated form of the enzyme in hydrolase activity, however in the case
of a mutase, this intermediate must be preserved while substrate reorients. In the case of
the cofactor-independent bisphosphoglycerate mutases (iPGM) of the alkaline phosphatase
superfamily the small substrates are found to reorient in a closed active site following the in-
tial phosphorylation event, preventing the unstable phospho-His moeity from being attacked
by water [81]. The catalytically similar, yet unrelated 2,3 bisphosphoglycerate dependent
bisphosphoglycerate mutases (dPGM), of the histidine phosphatase superfamily contains a
disordered C-terminal tail that interacts with the free phospho-His, stabilizing it while the
active site is solvent exposed [2].
In the HADSF it has been shown that, following βG16P phosphorylation of the nu-
cleophilic aspartate, the monophosphorylated glucose leaving group dissociates from the
enzyme, exposing the active site, and the unstable phospho-Asp to solvent [18]. Unlike
HAD hydrolases, which would immediately transfer this phosphate to a solvent water, in
the mutase reaction, the the phospho-Asp must be stabilized against hydrolysis until another
substrate enters the site, similar to alkaline phosphatase. The stability of this phosphoAsp
moeity is confirmed through a crystal structure of βPGM from Lactococcus lactis, show-
ing the solvent exposed phosphoAsp8 [82]. The complex mechanisms utilized by βPGM to
turn a hydrolase scaffold into a phosphomutase, which involve stabilization the phosphoAsp
and discrimination between solvent and substrate, have been previously proposed and are
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discussed below.
4.1.1 Regulatory Mechanisms in β-Phosphoglucomutase
The model of substrate specificity involving the cooperation between phosphate binding
sites in promoting conformational change of βPGM in Lactococcus lactis was discussed in
Chapter 2, where the initial activation step, phosphorylation of Asp8 by βG16P provides
1-2 kcal/mol of energy to assist in binding of the substrate βG1P or G6P. This synergistic
effect ensures that monophosphorylated substrate only binds to an active enzyme with Asp8
phosphorylated.
The acid/base catalyst, Asp10 is conserved in the HADSF and required for catalysis in
βPGM [83], as well as other HADSF members [14, 23, 84]. This aspartate has been shown
to stabilize the pentavalent transition state in the HADSF [49] and mutation of this residue
is observed to ablate all or nearly all activity [22]. In the majority of HADSF members,
this catalytic residue is fixed in position via a hydrogen bond to a residue in the core
domain, which is conserved neither in identity nor position among superfamily members.
In βPGM, His20 in the cap domain is observed to form a bridging hydrogen bond with
Asp10 and Lys76 in the closed, catalytically competent state, however, in the open crystal
structure, this hydrogen bond is broken and the Asp10 is found swung out of its catalytically
active position [20]. This inactivation is thought to allow the phosphoaspartate to remain
stable, in contrast to the other HADSF members which quickly transfer this intermediate
state to a water residue; hence they function as hydrolases. The swung-out state of the
acid/base catalyst is observed in one other HAD subfamily, phosphomannomutase [23],
the only HADSF member besides βPGM to have achieved mutase activity. Thus, the
positioning of this acid/base catalyst is seen as a crucial regulatory innovation for evolution
of mutase activity.
The proposed mechanism of βPGM includes an acid/base catalyst, Asp10, which must
undergo pKa cycling to perform its hypothesized role in the phosphate transfer reaction.
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During the catalytic step transferring phosphate from the phosphoAsp8 to the C1 or C6
hydroxyl of glucose, Asp10 acts as a general base, abstracting the proton from the hydroxyl,
allowing the oxyanion to act as a nucleophile to attack the phosphate. Asp10 must act as
an acid in the reverse step, donating a proton to the sugar hydroxyl leaving group following
phosphate transfer from the sugar to Asp8. The pH optimum of the enzyme has been
determined as pH=7.0 [18], indicating that the pKa of Asp10 has been shifted from its
solution value of 4.2 to near or above the pH range of the enzyme.
The complex microenvironments found in the ordered residues of active sites have been
observed to change the effective pKa of ionizable residues within. These microenvironment
effects allow for groups with pKas far from physiological condition to participate in proton
transfer reactions. Electrostatic effects provide the majority of the contribution to pKa
shifts, as observed in BPTI and lysozyme [85], however, the hydrophobicity of the site has
a great effect on the preferred charge state: a hydrophobic environment will favor a neutral
charge, while a polar environment will be more favorable to a charged state [86]. Lys116 of
acetoacetate decarboxylase was observed to drop 4.5 pKa units to 6.0 [87] due to desolvation
effects from burial of the amino group in a hydrophobic environment [88]. Full quantification
of these effects requires quantum simulation [89], however methods based on the finite-
difference Poisson-Boltzmann equation have shown good agreement with experiment [85,86].
Observation of pKa cycling of carboxyl residues in xylanase has been attributed mainly
to electrostatic perturbations in the active site during the catalytic cycle [90]. The highly
charged environment of the acid/base catalyst aspartate in the βPGM active site, containing
hydrogen bonds to His20 and Thr16 and proximity to phosphate and Mg2+, suggest that a
similar scenario of pKa shifts coupled to the catalytic cycle is reasonable [see Figure 4.1].
62
Figure 4.1: Scheme of possible activation pathways linking the open, unliganded,
Asp10 inactive state of βPGM (EO) and the catalytic complex (∗ECS). EO and EC
indicates the open and closed enzyme conformations, repectively. S indicates bound
substrate and ∗ represents that Asp10 is swung into the active site in the active
position.
Thus, βPGM requires four distinct events to occur to transition from the open, unli-
ganded system to the catalytic complex: Substrate binding, conformational transition to
the closed state, swinging of Asp10 into the active site, and protonation of the Asp10 car-
boxylate. The relationship between substrate binding and the conformational transition
were discussed in Chapter 2, where the substrate binding to the distal phosphate site was
found to induce the major conformational transition. This work seeks to understand the
interplay between conformation, ligand state and the activation, utilizing a computational
study focusing on the swing state of the Asp10 dihedral and protonation state of the Asp10
carboxylate. The role of protein conformation and the presence of ligand on each of these
events is determined and a model for the sequential events in the activiation pathway of
βPGM is developed.
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4.2 Methods
4.2.1 Protonation State Calculations
The probability of observing a given protonation state of a residue in the protein envi-
ronment at a given pH can be formulated as described by Bashford and Karplus [86]. In
this formulation, the pKa of the titrating group, the pH at which each protonation state
is 50% probable, is used as the reference condition and all perturbations to this value are
considered to arise solely from electrostatic effects. In a pure solvent environment, the free
energy of protonating a single titratable site at a given pH can be expressed in term of the
pKa as
∆GpH = 2.303 · kbT ∗ (pH − pKa) (4.1)
In a protein environment, however, electrostatic and solvation effects will modulate this
free energy. The electrostatic potential observed at a certain site can be approximated
as two components: fixed charges, which do not modulate charge during a titration. The
protein environment also imposes a solvation energy term on the site. Thus, the electrostatic
free energy of protonating a single site, s within a non-standard electrostatic environment
is seen as
∆GpH = 2.303 · kbT [pH − pKa,std] + Eback + EBorn − EMback − EMBorn (4.2)
where pKa,std is the reference pKa of the titratable site, Eback is the electrostatic inter-
action energy between the titratable site and all background charges and EBorn is the Born
self-energy for the given protonation state. EMback and E
M
Born are the corresponding electro-
static and solvation interaction energies of the model compound, which is the titratable
residue of interest in pure solution, which has pKa=pKa,std.
Macromolecules generally contain numerous titrateable side-chains, however, and the
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differential electrostatic interactions of each protonation state of each titratable site with
each other must be considered. In this instance, the electrostatic effects at a given site are
decomposed into two quantities: the fixed charges, which do not change with respect to the
pH, and the titratable charge centers, which will change depending on the protonation
state of its titrating site and, in effect, the pH. The total electrostatic free energy of a
complex with N titratable sites at a given pH and titration state s can then be described
as in equation 4.3.
∆Gs,pH = 2.303·kbT
∑
N
i=1[n(si)pH−pKa,i,std(si)]+Einter+Eback+EBorn−EMback−EMBorn
(4.3)
where s = (s1, s2, ..., sN ) is the vector that specifies the protonation state of each
residue, i, (0 for unprotonated and 1 for protonated in a two state site. This can be
extended, theoretically, to an infinite number of states), n(si) is the number of protons
in charge state si and Einter is the interaction energy between titratable sites. In this
treatment, it is convenient to define a standard reference protonation state, where each
titratable site has neutral charge.
The Born energy, EBorn,i, represents the free energy required to solvate charge i with
protonation state si at point, ri with the polarization induced by that charge at the same
point in space, Φ(ri, ri). The energy associated with this interaction is represented as the
electrostatic solvation free energy of a spherical ion [Equation 4.9].
EBorn,si = (q
2
i /2)Φ(ri, ri) (4.4)
Eback,si is the perturbation in the free energy of protonation at site i with protonation
state si due to a total of J fixed background charge centers is based on the sum of the
polarization at point ri from each individual j in J [Equation 4.10].
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Eback,si =
∑
J
j=1(qiqj)Φ(ri, rj) (4.5)
Finally, the perturbation due to interactions with titratable charge centers, Eback,i, is
based on the sum of the polarization at point ri from each individual j in J [Equation 4.11].
Einter,i =
∑
J
j=1(qiqj)Φ(ri, rj) (4.6)
Electrostatic potentials were computed using a linearized form of the finite-difference
Poisson-Boltzmann equation, as implemented in the UHBD program [91].
The occupation of each protonation state for each site i at a given pH was calculated
by minimizing equation 4.4 for all values of si using the Monte Carlo (MC) algorithm of
Beroza [92], as implemented by Schaefer [93] to handle sites with >2 distinct protonation
states. The method randomly assigns a state for each titratable site and successive states
are generated stochaistically by randomly changing the protonation state of a single site i
in a MC step. The change in free energy, ∆G, of this change is calculated as in equation
4.3.
For each pH value, 5000 equilibration MC steps, followed by 10,000 MC steps were
performed. The average protonation state for each site is determined using the statistical
average of 2,000 MC steps at each pH value, spanning a range from -10 to 20. A value of
80.0 for the dielectric of the solvent volume is used by convention.
The average occupancy ( P (s′i, pH) ) of each protonation state si for site i at a given
pH is
P (s′i, pH) =
∑
s
δsi,s′ie
−∆G
s,pH/kbT∑
se
−∆G
s,pH/kbT
(4.7)
where δsi,s′i = 1 if si = s
′
i and 0 if not. The effective pKa in the protein environment
determined from this method for a two state system is the point where s0 = s1 = 0.5.
66
Choice of Parameters and Structure Preparation
Partial charge data for each atomic center was derived from CHARMM27 parameters and
the glucose 1,6 bisphosphate ligand constructed from the previously derived CHARMM
parameters [see Section 3.2]. The pKa standard for the first protonation event of the 1-
and 6- phosphates of βG16P were approximated as the pKa values for G1P (6.13) and G6P
(6.11) [94], respectively.
Choice of the dielectric constant for the nonsolvent volume (EPSI) is particularly crucial
to these calculations. The experimental value for the dielectric of the protein interior has
been found as 4.0 [85], however computational use of this value yields inaccurate results.
Increasing the value of EPSI to between 10.0 and 20.0 has been shown previously to more
accurately represent the titration states of protein residues [85, 93, 95, 96]. EPSI values
of 10.0, 15.0 and 20.0 were used in these calculations, while the dielectric for the solvent
volume is set to 80. Electrostatic calculations were performed with a 150 mM ionic strength,
temperate of 298K and Stern layer of 2.0 Å. Final grid spacings of the focusing grid were
0.3 Å. Standard residue pKas were used from previous works [96]. The bisphosphorylated
ligand, βG16P, was treated as two separate protonation sites for the purposes of these
calculations. Phosphate esters have two potential protonation events, however only the
first protonation event (di-anionic to mono-anionic) was considered, as the pKa for the
second protonation (resulting in a neutral site), occurs well below physiological pH (0.0-
1.0). The standard pKas values used for these sites were set as the solution pKa values for
glucose 6-phosphate (6.11) and glucose 1-phosphate (6.13), respectively [94].
The choice of atomic structure for which the calculations of these methods are based
has been shown to be of great importance [95]. The X-ray crystal structure of βPGM with
intermediate βG16P bound as a phosphorane adduct to the catalytic Asp residue [20], was
utilized for the catalytic complex, while the X-ray crystal structure of the holoenzyme, with
only Mg2+ bound was used as the starting point for the open enzyme conformation. Docking
of the ligand into the open conformation was performed by superimposing the backbone
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atoms of the static active site residues Asp8, Asp10, Lys145, Asp169 and Glu170 of the
open configuration onto the closed protein. This overlays the active sites and allows direct
placement of the βG16P coordinates from the closed crystal structure onto the open system.
The position of the Asp10 carboxyl was set by manipulating the N-Cα-Cβ-Cγ dihedral angle
with the value of -180◦ for the swung out and -60◦ for the swung in positions, as observed
in the closed and open crystal structures, respectively. Hydrogens were added using the
HBUILD function in CHARMM and the resulting structure gently minimized with 50 steps
of steepest descent followed by 250 steps of Adapted Basis Newton-Raphson (ABNR) with
the positions of heavy atoms fixed. A second minimization of 50 stepest descent and 250
ABNR steps was performed with no restraints. All model building and minimization was
performed in CHARMM version C36a3 using the default nonbonded parameters [66].
A paradox exists when preparing structures for pKa calculations, as the protonation
state of the system must be pre-determined to perform the minimization necessary to relax
high-energy contacts. This choice of states invariably biases the results towards the proto-
nation state chosen, as the minimization of the environment surrounding a residue with an
assigned proton will cause the relaxing groups to accomodate this state, resulting in a lower
free energy for this protonation event. This effect was mitigated in the region of interest, the
active site, by identifying the titratable residues that interacted with the residue of interest,
Asp10, in the active pH range of the enzyme (6.0 to 8.0) [18]. The different permutations
of the protonation states for these residues and Asp10 were tested in each conformational
state to ensure the observed trends were not due to this initial system bias.
There is no available experimental pKa data for individual residues of βPGM, making it
difficult to confirm the computational model and choose a respresentative value for EPSI. As
an alternative, the pH-rate profile for the enzyme was determined, showing a pH maximum
for kcat at pH 7, and showing effective pKa values for two essential acids, at pH 4.7 and 6.7;
and one essential base residue with a pKa of 7.3 [18]. pH-rate profiles were generated from
calculated titration calculations by multiplying the probabilities of each catalytic residue
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being in the correct protonation state. Based on the proposed mechanism, these states are
assumed to have Asp10, Lys76 and Lys145 protonated; Glu169 and Asp170 unprotonated
and His20 is singly protonated at N [Fig 4.2]. The protonation state of the transferring
phosphate site, GP1, is unknown. In solution, the hydrolysis rate for phosphoryl monoesters
is highest at pH 4.0, where the singly protonated form is dominant [97], and quantum
treatment of the phosphorane transition state generally utilizes a proton on one of the
equatorial oxygens [98], however in an enzymatic environment, protonation has not been
explicity observed. As such, both the mono and di-anionic states of the GP1 site are
considered.
Lys145
Glu169
Asp8
Asp170
Asp10GP1
Lys76
His20
Residue State Function
Asp8 Unprot Nucleophile
Asp10 Prot - OD2 Acid/Base catalyst
His20 Prot - N Coordinates Asp10
Lys145 Prot Coordinates GP1
Glu169 Unprot Coordinates Lys145
Asp170 Unprot Coordinates Mg2+
GP1 Prot/Unprot Transferring phosphate
Figure 4.2: Predicted protonation states for active βPGM. Left: Close up of active
site residues in active protonation state. Right: Table of residues with protonation
states
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4.2.2 Asp10 Dihedral Swing Free Energy Calculations
In order to predict the preferred conformational position of the Asp10 carboxyl, a 2D
potential of mean force (PMF) was generated for the residue torsion angle on the N-Cα-
Cβ-Cδ atoms. Initial structures were generated from the crystal conformations of βPGM
and ligand introduced as discussed in section 4.2.1. The torsion angle was rotated in
CHARMM in 5 degree increments and minimized as above, resulting in 72 structures for
each conformational state. The resulting structures were further minimized in NAMD [70]
version 2.9 utilizing a parallelized version of the generalized Born implicit solvation (GBIS)
method [99,100]. Values of 150 mM were used for the ion concentration, with an electrostatic
cutoff distance of 16.0. Inclusion of implicit solvent hydrophobic energy terms were not
observed to change results and therefore were not included to improve computational speed.
Default dielectric values for protein (1.0) and water (78.5) were used in minimization.
Systems were integrated using Langevin dynamics at 300 K, a 2 fs timesstep and a 1/ps
Langevin damping coefficient [101] in NAMD. Rigid bonds were enforced throughout. For
all systems, a 1 kcal/mol restraint on the position of Cα atoms was applied to ensure that
the spontaneous conformational changes observed in Chapter 3 did not occur. The Asp10
sidechain was held in position with a 1 kcal/mol restraint. Fifty picoseconds of equilibration
was performed.
Following equilibration, three 100ps runs were performed with the value of the restrained
dihedral logged every 20fs, resulting in 5000 observations of the Asp10 dihedral per sampling
window. Each production run was individually integrated using WHAM to produce the 1D
PMF over the side-chain dihedral angle of Asp10. The three resulting PMF's for each state
were averaged, resulting in 21.6 ns of total analyzed simulation for each resulting PMF.
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4.3 Results and Discussion
4.3.1 Factors Affecting the Protonation State of Active Site Residues
Influence of Initial Protonation State and EPSI on Asp10 Protonation
The protonation probability of the acid/base catalyst Asp10 in the closed, ligand bound
conformation of the enzyme was calculated using initial structures minimized from crystal
coordinates with different assigned protonation states for the Asp10 and GP1 sites: Both
unprotonated; GP1 protonated, Asp10 unprotonated; Asp10 protonated, GP1 unproto-
nated; and both sites protonated. Each protonation state was minimized from the crystal
coordinates as described above with no dihedral restraints. For each state, three values
of the internal dielectric (EPSI) parameter were used in electrostatic calculations to asses
this parameters' effect on the Asp10 site at atom OD2 at the pH maximum of the enzyme
(7.0) [18]. The probability of a proton on this site was found to be non-zero in all cases,
with the choice of internal dielectric and initial protonation state significantly affecting the
calculated probability [Table 4.1].
The low EPSI value of 10.0 favors a proton on Asp10, with all initial protonation states
observed to have greater than 90% chance of protonation at this level. The probability
lowers to 10 to 64% with the higher dielectric value of 20.0. A higher dielectric constant
provides a lower solvation free energy for unpaired charges, explaining the stabilizion of the
unprotonated state of Asp10.
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Proton RMSD EPSI
Asp10 GP1 (Å) 10.0 15.0 20.0
  0.0137 0.909 0.390 0.109
 + 0.0251 0.530 0.201 0.083
+  0.0299 1.000 0.962 0.639
+ + 0.0256 0.980 0.926 0.390
Table 4.1: Table of protonation probabilities for Asp10 OD2 at pH=7.2 in catalytic
complex (PDBID: 1O03) with differing initial protonation states and internal dielec-
tric value (EPSI). RMSD values for each minimized structure with respect to the
crystal coordinates
The initial protonation state was found to significantly influence protonation at this site
as well, by inducing small perturbations in the positions of the charged active site groups
following minimization. These small conformational changes affect the pairwise interaction
energies between the charged sites. Minimizing the closed crystal structure with a proton
on Asp10 significantly biases the calculated probability towards favoring protonation, as the
protonated carboxyl is brought in proximity to the C1 ester oxygen via a hydrogen bond.
The structure minimized with no protons at either site moves the Asp10 carboxyl away
from the transferring phosphate group, significantly reduceing the protonation probability.
Influence of Initial Protonation State and EPSI on Computed pH-Activity
Profile
Computed pH-activity profiles were calculated as described in section 4.2.2 for all confor-
mations and EPSI values described in the previous section [Figure 4.3]. In all cases, these
activity profiles show a maximum in the range 7.0 ≤ pH ≤ 9.0, which is similar to the pH
range of the enzyme (6.0 ≤ pH ≤ 7.5). In all cases, the calculated pH maximum for kcat
is higher than the experimental value of 7.0. The low dielectric of EPSI=10 shows broad
activity over a huge range of pH values, while EPSI=20 shows a much more narrow profile.
The intial protonation state also has a large effect on the computed rate profiles. Cal-
culations employing the proposed correct catalytic state (Asp10 protonated and GP1
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unprotonated), in all cases produces the broadest activity profile, with the highest activ-
ity at most pH values [Figure 4.3, blue]. The other starting state containing one proton,
with GP1 protonated and Asp10 unprotonated [Figure 4.3, blue], shifts the pH maximum
of the enzyme slightly higher. In all cases, the narrowest activity profile is seen with the
unprotonated active site, while the doubly protonated active site is similar to the Asp10
protonated state at EPSI=10 and EPSI=15, while more similar to the GP1 protonated
state at EPSI=20.
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Figure 4.3: Computed pH-activity profiles for each intial protonation state and
value of EPSI. Protonated residues are printed in bold. The product of the proba-
bilities of the catalytic protonation sites being in the correct state were calculated
and scaled so the maximum probability = 1 for each curve. The initial state pro-
tonating only Asp10 is shown. Other protonation states showed similar protonation
trends.
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The protonation states of the active-site residues identified in Table 4.2 were plotted as a
function of pH to observe the protonation events that affect the computational pH-activity
profile on the acidic and basic sides [Figure 4.4]. Three sites are observed to titrate in the
pH-activity range of the enzyme: Asp10 has both a protonation and deprotonation event,
His20 deprotonates at its N and GP1 deprotonates. All other residues are observed to be
in their catalytic protonation state throughout the pH range of interest. The non-sigmoidal
nature of each of the three titrating events indicates a non-Henderson-Hasselbach behavior
of these titration events. The close proximity of these sites in the active site suggest that
these titrations are coupled.
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Figure 4.4: Number of active site protons (Asp10, GP1 and His20) predicted over
the active pH range of the enzyme for each initial protonation state and value of
internal dielectric (EPSI).
The titration curve for Asp10 is observed to have the greatest degree of non-ideality,
with two pH-maximums for protonation at atom OD2. The first maximum occurs at pH=-3
or lower and the second peak at in the 7.0-7.5 range, with small differences observed by
changing the EPSI value. The intermediate pH values see a lower probability of protonation
at this site, which appears to be concerted with the loss of a proton at the His20 N. At
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EPSI=10, His20 titrates below pH=-5, resulting in a deprotonated site above this pH.
The loss of this proton is coupled with a high probability of protonation at the Asp10
site throughout the intermediate pH values of 0-7. At higher EPSI values, however, His20
protonates at higher pH values, and the continued presence of this proton is co-observed to
lower the probability of protonation at Asp10. The GP1 site also appears to affect Asp10
protonation, as its titration event between pH=0 and pH=7 appears coupled to the second
protonation peak of Asp10. As is the case with His20, the loss of a proton at the proximal
GP1 site appears to promote the gain of a proton on the catalytic Asp10. The coupling of
these events suggest that these three sites are sharing protons.
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The total proton density among these three sites was computed at pH=7.2 for all EPSI
and and intial structural states, showing that in all cases, approximately 1 proton is expected
among the three residues [Figure 4.6]. The initial state which does not contain an active site
proton [Figure 4.6, red], shows the lowest proton density, while both the initial state with
two active site protons [Figure 4.6, purple] and a proton only on GP1 [Figure 4.6, green],
show a proton density slightly higher than 1. The no-proton and two-proton initial states
are consistent with protonation bias observed with this method. No physical interpretation
of the higher proton density for the GP1 state is offered. The initial state with only Asp10
protonated [Figure 4.6, blue], shows a single proton at all values of EPSI, in agreement with
the catalytic mechanism. All proton density results suggest that the active site residues,
His20, GP1 and Asp10 share a single proton in the active site at catalytic pH.
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Figure 4.6: Plot of protonation density of active site residues vs. Asp10 swing posi-
tion from initial starting structures with Asp10 protonated (left) and GP1 protonated
(right). Dihedral values corresponding to the swung-out position is highlighted in
blue, while the swung-in position is highlighted in pink.
The effect of each catalytic residue on the pH-activity profile can be observed. The
computed pH-activity profile [Figure 4.5, red pluses] shows a steep drop as the pH increases
above 8.0. This drop in catalytic probability is entirely dependent on the deprotonation of
the Asp10 site [Figure 4.5, orange] at all values of EPSI. The pKa of this acidic titration
event varies between pH=8 and pH=10 depending on the value of EPSI. The experimental
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pH-activity profile of βPGM identifies a single essential acid [18], which is in agreement
with computational results. The pKa of the essential acid event is calculated as 7.4 in
experimental results, which is lower than calculated results. The acidic portion of the curve
is more complex, with His20, Asp10 and the transferring phosphate, GP1 contributing to
the loss of activity at lower pH. The experimental pH-rate profile also shows complexity in
the acidic portion, fitting to a multiple exponential decay, rather than identifying a single
essential base. The contribution of His20 [Figure 4.6, blue] to the activity profile is highly
affected by the choice of EPSI parameter; at EPSI=10, the catalytic state of His20 is over
90% occupied at pH 0, while at EPSI=20, the pKa of His20 is found to be 6.5, where it
would greatly affect the catalytic activity. The complexity of the acidic titration curves
suggest that experimental results may not identify single titration events, but rather the
complex coupling between the three protonation sites discussed above.
Asp10 Dihedral Positioning Changes Protonation Scheme in Catalytic
Complex
The proton density of the three active site residues with respect to the N-Cα-Cβ-Cγ dihedral
angle of Asp10 was calculated to determine the effect of the positioning of the Asp10 car-
boxyl on the protonation states of active site residues in the closed, ligand bound complex.
Initial systems were constructed from the closed crystal structure with the Asp10 sidechain
dihedral rotated using CHARMM and subsequent minimization performed as described in
section 4.2.2. Both initial protonation states containing a single proton in the active site,
either on GP1 or Asp10, were used in this analysis.
In both cases, the total proton density among the three sites remained close to 1.0
[Figure 4.7, red] along the entire dihedral path, indicating that the side chain rotation does
does not affect the presence of the proton in the active site. This further implies that the
Asp10 side chain can be in either the swung-in or swung-out in the closed, ligand bound
state, without affecting the presence of the catalytic proton.
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The positioning of the Asp10 carboxyl was observed to have a significant effect on the
relative protonation densities of the Asp10, His20 and GP1 sites [Figure 4.7]. Asp10 is the
major location of the proton while swung into the active conformation (dih=-60◦). As
Asp10 swings out of the active site, its protonation probability decreases significantly, to
nearly zero when it is in the observed swung out position (dih=180◦). Coincident to this
change, the protonation density of both the GP1 and His20 sites increase, however in both
cases, it is the His20 that is predicted to have the highest density. In the initial protonation
scheme that does not include a protonated GP1 [Figure 4.7, left], the predicted protonation
of GP1 is negligible at all angles. In the state minimized with a GP1 proton [Figure 4.7,
right], the calculated protonation probability at this site increases slightly, however still
below that of His20, implicating His20 as the main residence of the active site proton when
Asp10 is swung out of the active site.
The location of the second proton on the His20 N is somewhat outside of the active site
in the closed crystal structure, making a hydrogen bond to the amine of Lys76. Protonation
of this site would destabilize the interaction between these two residues. In addition, to
pass this proton to Asp10 as necessary for catalysis, the His20 imidazole would have to flip
180◦ to position the proton towards the Asp10 carboxyl, while subsequently positioning the
protonated Nδ towards Lys76. Following this proton transfer, the imidazole would then
have to flip back to position the deprotonated N back towards the Lys76 amide and the
protonated Nδ towards Asp10, creating the hydrogen bond arrangement observed in the
transition state crystal structure. Histidine flips have been proposed in catalytic cycles,
most notably, the serine proteases [102]. The rate of flipping has been calculated as, and
found experimentally to occur at in serine proteases, which is significantly faster than the
turnover rate of βPGM, which is on the order of 60/s [18]. This suggests that this mechanism
is plausible, however the lack of this histidine residue in HADSF members outside of the
βPGM subfamily limits application of protonation of Asp10 via a coordinating histidine to
the entire superfamily.
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The alternative mechanism where the proton source is GP1, computed to be less prob-
able, involves proton transfer from the transferring phosphate to Asp10. The proton could
reside on any of the three phosphate oxygens. One of these oxygens, however, coordinates
Mg2+, and is unlikely to be protonated in any instance. Of the remaining two oxygens, one
makes three hydrogen bonds; the hydroxyl of Ser 114 and the amide hydrogens of Asp10
and Ala115. The other oxygen contains two hydrogen bonds, one to the amide hydrogen of
Asn 116 and the other to the amine of Lys145. The hydrogen bonding pattern of phosphate
oxygens has been shown to allow three hydrogen bonds [103], making a proton on the last
oxygen feasible. However, the distance from this oxygen to the OD2 of asp10 is 5.63, which
is too long to be bridged by a hydrogen. The second oxygen is positioned correctly, however
contains too many hydrogen bonds in the crystal structure to be able to stabilize a proton.
Likely, then, the proton transfer step and formation of the completely closed catalytic com-
plex are not independent events. Transfer of the proton could occur coincident with the
phosphate entering the active site and encountering the coordinating residues which would
promote deprotonation of the GP1 site.
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Figure 4.7: Titration curves showing the probability of Asp10 protonation vs. pH
for each structural state described in Fig 4.1. Calculations were performed at 3 values
of the protein dielectric, EPSI, 20.0 (Red), 15.0 (Green), 10.0 (blue). The light blue
box indicates the pH maximum region of the enzyme (pH 6-8). Top Row: No Ligand.
Bottom Row: βG16P Present.
Asp10 protonation requires the presence of phosphate in the transferring
site
The effect of enzyme conformational change, presence of βG16P in the active site and
the swing position of the Asp10 carboxyl on the protonation state of Asp10 at the OD2
position was calculated. Titration curves from pH=-10 to 10 for each state at three values
of EPSI=10, 15 and 20 are shown in Figure 4.8. Calculations show that the Asp10 site is
highly dependent on both the dihedral swing state and the presence of ligand, however less
so on the conformational state of the enzyme.
The presence of ligand in the active site is seen to increase the protonation at Asp10.
In all conformational states, the protonation probability of Asp10 without ligand is nearly
zero at physiological pH [Figure 4.8, top row]. Only in the presence of ligand, is significant
protonation observed, both in the open and closed enzyme conformation, however only with
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Asp10 swung into catalytic position [Figure 4.8, bottom row].
The swing state of the Asp10 carboxyl is also observed to have a major effect on pro-
tonation. When swung out of the active site protonation is highly unfavored regardless of
enzyme conformation or ligand presence [Figure 4.8]. This is likely due to its positioning
close to the divalent magnesium cation and other hydrogen bonding groups. In the swung-
in state, the central carboxyl carbon is 5.3 away from the catalytic Mg2+ ion, while in the
swung-out state this distance is 4.8 . In addition, in the swung-out state, Asp10 makes a
hydrogen bond with both the peptide nitrogen hydrogen of Thr16, in addition to the side
chain hydroxyl. Each of these events likely stabilize the unprotonated form of the carboxyl.
The conformational change is observed to have little effect on the protonation prob-
ability of Asp10, suggesting that desolvation of this site and proximity to His20 do not
significantly contribute to the energetics. This lack of effect is consistent with the mech-
anism of many HADSF hydrolases, such as D,D-heptose 1.7-bisphosphate phosphatase
(GmhB) [12] and 2-Keto-3-deoxy-D-glycero-D-galacto-nononate-9-phosphate phosphatase
(KDNPP) [13], which do not undergo a conformational change as part of the catalytic cy-
cle. In addition, both enzymes contain a core domain pinning residue for the acid/base
catalyst Asp, with an arginine in GmhB and lysine in KDNPP each observed to form a hy-
drogen bond with the carboxyl oxygen distal to the active site. The only major differences
between ligand-bound and ligand-free states of these enzymes are the presence of substrate
in the active site [12,13]. The catalytic acid/base aspartate residues still must undergo pKa
cycling as part of catalysis, implicating the substrate presence, and the proximity of the
negatively charged phosphate to the catalytic Asp as the mediator of its pKa shift.
4.3.2 Conformational and Ligand State Affect Asp10 Carboxyl Swing
The final conformational mechanism considered in βPGM is the swinging of the Asp10
dihedral, which is observed to be swung out of the active site in the holoenzyme and
swung in in the catalytic complex, undergoing a 120◦ rotation along its Cα-Cβ axis. To
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assess the impact of each of these conformational events on the swing state of Asp10,
umbrella sampling was performed along the N-Cα-Cβ-Cδ dihedral and the corresponding
PMFs analyzed to identify the lowest energy swing state of the carboxyl.
The open, unliganded enzyme shows a 3.2±0.2 kcal/mol preference for the unprotonated
side chain of Asp10 to be in the swung out position [Fig 4.8; top, red]. Changing the
conformational state of the enzyme to the closed position [Fig 4.8; top, green], has negligible
effect. Adding the ligand to the active site in the open conformation increases the bias
towards the swung out position by ˜1.8 kcal/mol [Fig 4.8; top, blue]. However, when closed
and in the presence of ligand, the equilibrium shifts, with the catalytic, swung-in state now
favored by 2.4±0.3 kcal/mol [Fig 4.8; top, pink].
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Figure 4.8: Plot of PMF vs. Asp10 dihedral angle in βPGM conformational states.
Top: Asp10 unprotonated. Bottom: Asp10 protonated. The dihedral values corre-
spondong to the swung-out position are highlighted in light blue, while the swung-in
position is highlighted in light pink. Error bars are 2σ.
A protonated Asp10 shows a clear bias towards the catalytic position in all states
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[Figure 4.7; bottom], except in the unliganded, open conformation [Figure 4.7(b); bottom,
red], where both conformations are energetically similar. Both the open conformation with
ligand and the closed conformations without ligand now favor the swung-in position by
2.2±0.2 kcal/mol. In the closed, ligand bound state, protonated Asp10 favors the swung-in
position by 3.8±0.4 kcal/mol over the unprotonated form.
All together, these calculations show that when protonated, Asp10 favors the catalyti-
cally active, swung in position. While this appears to be the major modulator of the free
energy surface, the conformational and ligand state also appear to play a role, as formation
of the closed, ligand bound complex is sufficient to change the equilibrium position of the
aspartate side chain without protonation.
4.3.3 Model of βPGM Catalytic Complex Formation
Taken together, a model for construction of the catalytic complex of βPGM can be hy-
pothesized, beginning from the free enzyme state in the open conformation, with no ligand,
Asp10 swung out of the active site and unprotonated. The ligand induced conformational
change discussed in chapters 2 and 3 highly suggests an induced-fit mechanism, where sub-
strate will bind to the open conformation of the enzyme. At this point, the open, ligand
bound enzyme does not promote the protonation of Asp10 [Figure 4.6], nor does it promote
the swinging of the Asp into the active site [Figure 4.7(a)], suggesting that the next step in
the activation mechanism is enzyme closure.
Following this step, Asp10 in the closed, ligand bound, swung out state is still predicted
to be unprotonated [Figure 4.5(a) top right], as proximity to the divalent magnesium elec-
trostatically blocks any protonation events. However, at this point, the equilibrium posi-
tioning of the Asp10 carboxyl changes, to favor the swung in state [Figure 4.7(a), pink].
As Asp10 swings across the active site and is drawn into catalytic position, its electrostatic
environment changes, favoring protonation at this site [Figure 4.5], with the source of this
proton is likely from a doubly protonated His20, or the transferring phosphate group. Once
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protonated, the equilibrium positioning of the Asp10 is further directed towards the swung
open state [Figure 4.6(b), pink], successfully completing the catalytically active complex of
the enzyme.
Figure 4.9: Scheme of possible activation pathways from Figure 4.1 showing the
possible activation pathway steps and relative equilibria observed from this work.
βPGM (EO) and the catalytic complex (∗ECS). EO and EC indicates the open and
closed enzyme conformations, repectively. S indicates bound substrate and ∗ repre-
sents that Asp10 is swung into the active site in the active position. Red indicates a
conformational state that is predicted to be protonated, while black is predicted to
be unprotonted. Purple represents the structural state where the protonation state
could not be confidently assigned.
4.4 Conclusions
βPGM has evolved a unique and complex regulation method requiring three events be
completed for successful activation of the enzyme by substrate: conformational transition,
swinging of the Asp10 acid/base catalyst into the active site, and protonation of the catalytic
Asp10 carboxyl. The specific adaptation of the swinging acid/base catalyst aspartate is
unique, and necessary to prevent stabilizing of the phosphorane while the active site is
open and exposed to water. The coupling of this swing to the correct positioning of the
ligand and full closure of the enzyme ensures that this residue will only be in place when
all other components to catalysis are satisfied.
The data presented above show a clear interplay between between each of these reg-
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ulatory mechanisms that, together, provide a multi-step activation sequence that allows
βPGM to discriminate between substrate and solvent. The presence of ligand and subse-
quent conformational change drives the repositioning of the catalytic Asp10 carboxyl, which
subsequently becomes protonated to form the catalytic complex.
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Chapter 5
Conclusion
5.1 Summary
This work has studied the activation mechanisms of β-phosphoglucomutase (βPGM) from
Lactococcus lactis using small angle and wide angle X-ray scattering (SAXS, WAXS) and
molecular dynamics (MD) to describe the substrate induced activation mechanisms that
allow this enzyme to discriminate between substrate and solvent, turning an efficient phos-
phohydrolase scaffold into a phosphomutase. The natural ligand to apo βPGM is β-glucose
1,6 bisphosphate, which binds to the enzyme with either phosphate group in the catalytic
transferring phosphate site, the hexose ring in the sugar site and the second phosphate in
the distal phosphate site, located away from the active site. Activation of βPGM requires
four distinct steps: binding of ligand to the active site, a conformational change that closes
the enzyme, swinging of the catalytic acid/base Asp10 into active position, and a shifting
of the electrostatic environment to allow protonation of the acid donor Asp10.
The nature of the conformational change of βPGM was studied by observing the confor-
mational ensemble of the enzyme in complex with various ligand pieces occupying part, or
all of the enzyme active site. Observation of the ensemble was performed using low resolu-
tion experimental (SAXS and WAXS) and high resolution computational methods (all-atom
MD). Results showed that the stabilization of the closed state of the enzyme is stabilized by
ligand moieties that are able to bind to a low-affinity distal phosphate site, while binding of
ligand to the high-affinity catalytic transferring phosphate site has only a small effect on the
enzyme conformational state. Binding to the transferring site was, however, shown to have
a 1.8 kcal/mol synergistic effect on binding at the transferring site, indicating that binding
to this site reduces the conformational energy barrier between the two states. These results
are in agreement with recent enzyme theory implicating the binding energy of non-reactive
87
portions of the substrate/enzyme complex driving the conformational change required for
enzyme activation [63].
The dependence of the protonation state and positioning of Asp10 of the conformational
and ligand state were analyzed independently using computational methods. The proba-
bility of protonation of Asp10 was determined by calculating the effects of the electrostatic
environment in each state using the linearized finite difference Poisson-Boltzmann equation
and sampling protonation states with a Monte Carlo method [96]. Significant electrostatic
effects are observed when Asp10 is swung into catalytic position in the presence of bispho-
sphorylated ligand, predicting a significant percentage are protonated, while without the
presence of ligand, or when Asp10 is swung out of the active state, electrostatic effects
are biased against protonation. The equilibrium position of Asp10 was studied using free
energy molecular dynamics simulations, showing a synergy between protonation and ac-
tivation: protonated Asp10 is far more likely (by 2-4 kcal/mol) to reside in the catalytic
position, while unprotonated Asp10 is highly biased towards the non-catalytic position.
The exception is unprotonated Asp10 in the closed, ligand bound state, which favors the
catalytic position by 3 kcal/mol, implicating the protonation of Asp10 dependent on the
correct positioning of the residue within the active site.
Taken together, a model for the activation of βPGM that provides mutase activity
can be proposed, where the initial state is an open, unliganded enzyme with Asp10 in the
inactive position and unprotonated. The ligand, βG16P binds with one phosphate in the
high-affinity catalytic transferring site, however it is the presence of second phosphate in the
distal site that drives the conformational change. Once the closed state has been achieved,
the equilibrium position of Asp10 is shifted towards the catalytic state. Upon correct
positioning of the Asp10, its electrostatics now favor protonation of the site, resulting in the
catalytically competent complex. The evolution of these multiple layers of substrate-induced
activation in βPGM allows the enzyme to prevent unproductive transfer of phosphate to
water, which is critical for mutase activity.
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5.2 Future Work
5.2.1 Second Binding Step of βPGM
The computational portions of these studies focused on the binding step and catalytic
complex formed by β-glucose 1,6 bisphophate and apo β-phosphoglucomutase. A second
reaction step involves the binding of a monophosphorylated sugar (βG1P or G6P) to βPGM
phosphorylated at Asp8. In this scenario, the Asp10 residue should be unprotonated to act
as the general base catalyst and deprotonate the sugar hydroxyl in the catalytic complex.
Free energy simulations of the Asp10 swing position with respect to enzyme conformation
and Asp10 protonation are expected to produce similar results to that observed in this
work.
In our studies, the wild type enzyme has been the primary model used. One aspect
of the conformational change that was not thoroughly investigated is the rearrangement
of the linker domain, comprising a shift in the backbone dihedral angles of Asp15, as well
as a flipping of the Thr16 side chain that forms a hydrogen bond with the critical Asp10
catalytic residue that was a focus of this study. Fixing of the Asp15 backbone dihedral
angles in the closed conformation was observed in equilibrium dynamics to prevent the
enzyme from progressing into the open state. An additional set of free energy simulations
along these two dihedral angles with respect to protein conformation and ligand state could
help to identify the specific event that causes transition between states.
Kinetic analysis of the Thr16Pro mutant show reduced catalytic efficiency of the en-
zyme, as well as reduced fidelity for substrate over water, while the structure is observed
crystallographically to be in the open position [22]. The effect of this proline mutation is
twofold: first, it removes the hydrogen bond connecting the Asp10 carboxyl to the linker
region and second, it fixes on of the linker region dihedrals in the open conformation. So-
lution scattering data collected as part of this project, but not presented confirms a more
extended structure than the wild type in both in the presence of transition state analogue
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G6P and VO3− and no ligand as compared to the wild type. It would be interesting to do
a detailed solution scattering titration of the distal site using G6P to see how fixing the
linker region dihedrals affect the ability of the transferring site to form.
Structural characterization via solution scattering could be performed on those mutants
that have been kinetically shown to affect emphkM and emphkcat values. In particular,
mutations to His20, which makes a stabilizing hydrogen bond with the catalytic Asp10 in
the closed conformation, are observed to significantly emphkcat while having little or no
effect on emphkM [22].
5.2.2 Elucidation of evolutionary pathway of βPGM
As discussed in the introduction, mutase function is rare in nature. As such, the evolutionary
pathway by which an enzyme gains mutase function is of particular interest. Preliminary
studies have been performed along this topic, finding the nearest evolutionary neighbors of
βPGM in the HADSF type 1A subfamily and studying the differences between the sequence
and structure of βPGM and its relatives.
In the HADSF, mutase activity has independently evolved twice: one event resulting
in the βPGM subfamily, while another, separate event resulted in phosphomannomutase
(PMM) mutase. Notably, both enzymes are observed crystallographically to have their
catalytic acid/base aspartate residues swung out of the active site when captured without
ligand [Figure 5.1], yet these enzymes are found in completely different subfamilies within
the HADSF. This observation highlights the importance of this swinging dihedral mecha-
nism in evolving mutase activity. However, it is not known if simply evolving this swinging
mechanism is enough to turn the hydrolase scaffold of the HADSF into a mutase.
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Figure 5.1: Overlay of nucleophilic and acid/base catalyst aspartate residues from
βPGM in the closed conformation, with acid/base catalyst Asp swung into catalytic
position (red), open conformation with Asp swung out of active site (blue), and
PMM in the open conformation, also with catalytic Asp swung out of the active site
(brown).
Recent work in the lab of Doug Theobold has used bioinformatic techniques to predict
the sequence and structure of major evolutionary break points in lactate and malate de-
hydrogenase [104]. Their results have shown the likely evolutionary pathway between the
ancient gene duplication event and functional divergence of the daughter enzymes into their
modern catalytic profiles, identifying the mutations that contribute the most to shifting ac-
tivity from malate to lactate. By employing similar methods with βPGM and PMM, the
ancestral enzymes of these two enzymes can be determined, as well as the critical mutations
that changed their catalytic profile from mainly hydrolase to mainly mutase.
Preliminary Methods
The set of all HADSF members from the type 1A subfamily (~45,000 total) was collected
from all annotated sequences listed in the InterPro database [105]. The number of se-
quences was reduced by clustering first by genus, and then 90% sequence identity, resulting
in a set of 1,958 unique sequences. A multiple sequence alignment and evolutionary clado-
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gram were produced using Clustal Omega [106] and the cladogram analyzed to identify the
nearest neighbors of βPGM. Available structural coordinates for these related enzymes were
searched for in the PDB.
Preliminary Results
The cladogram shows that βPGM has evolved from prokaryotic phosphoglycolate phos-
phatases (PGP), which catalyzes the hydrolysis of the small metabolite phosphoglycolate
[Figure 5.2]. Sequentially similar to βPGM are enzymes that work on larger substrates,
such as pseudouridine 5' monophosphatase (pUMPase), fructose 1-phosphate phophatase
(F1Pase), 2-deoxyglucose 6-phosphatase (dG6Pase) and mammalian PGP [Figure 5.2(b)].
Structures of mammalian PGP (PDBID: 2YY6), pUMPase (3L5K) and dG6Pase (1TE2),
allowing the comparison of the structural features with the residues known to be important
in the regulatory mechanism of βPGM [Figure 5.3].
First analyzed were the residues that coordinate the positioning of the acid/base catalyst
Asp+2 [Figure 5.3, green]. All related enzymes contain the linker region Ser/Thr six residues
downstream from this catalytic Asp, however in all three related enzymes with structural
data, a second pinning residue is observed to reside in the core domain. This residue is
either a lysine or a serine located between beta strand 2 and helix 2 in the core domain.
The presence of a pinning residue in the core domain stabilizes the carboxyl in the active
position, independent of the positioning of the cap domain. Without this conformationally
dependent positioning of the catalytic Asp, when the active site is open and solvent exposed,
the phospho-Asp intermediate is still coordinated by the catalytic acid/base aspartate.
Electrostatic calculations from chapter 4 showed that the presence of the phosphorylated
ligand in the active site is sufficient to raise the pKa of this aspartate into the physiological
range, allowing it to perform its function and catalyze the transfer of phosphate to water.
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(a)
(b)
Figure 5.2: Identification of Sequential Relatives of βPGM (a): Cladogram of all
HADSF C1 family members (b): Close up of non-prokaryotic PGP section of tree
diagram highlighting the separate clades, annotated by function. Those clades con-
taining an enzyme with high resolution structural information available are marked
by a blue star.
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(a) βPGM (b) PGP (c) pU5'MP
(d) 2dG6PP (e) YqaB
Figure 5.3: Cartoon representation of close sequence relatives of βPGM highlighting
the Asp+2 catalyst (red), Asp+2 coordinating residues (green) and the residues
that interact between the cap and core domains (cyan). The Asp nucleophile is
colored blue for reference. Helix 2 and helix 3 of the cap domain are omitted for
clarity. (a): βPGM (PDBID: 1O03) (b): Phosphoglycolate phosphatase (2YY5)
(c): pseudouridine 5' monophosphatase (3L5K) (d): 2-deoxy glucose 6-phosphate
phosphatase (1TE2) (d): Gene product YqaB, hypothetical fructose 1-phosphate
phosphatase (Threading model created with Phyre2 utilizing 1O03 scaffold)
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First analyzed were the residues that coordinate the positioning of the acid/base catalyst
Asp+2 [Figure 5.3, green]. All related enzymes contain the linker region Ser/Thr six residues
downstream from this catalytic Asp, however in all three related enzymes with structural
data, a second pinning residue is observed to reside in the core domain. This residue is
either a lysine or a serine located between beta strand 2 and helix 2 in the core domain.
The presence of a pinning residue in the core domain stabilizes the carboxyl in the active
position, independent of the positioning of the cap domain. Without this conformationally
dependent positioning of the catalytic Asp, when the active site is open and solvent exposed,
the phospho-Asp intermediate is still coordinated by the catalytic acid/base aspartate.
Electrostatic calculations from chapter 4 showed that the presence of the phosphorylated
ligand in the active site is sufficient to raise the pKa of this aspartate into the physiological
range, allowing it to perform its function and catalyze the transfer of phosphate to water.
Also observed is the nature of the interaction at the interface of the cap and core
domains between helix 3 of the cap and helix 2 of the core domain [Figure 5.3(b)]. In
each analyzed structure, this interface is comprised of hydrophobic residues, whereas this
interface of βPGM is comprised of small, hydrophilic side chains and held together via an
Asn-Asn bridge. The implication of this is restricted ability of the cap and core to separate
completely in the non-mutases, in contrast to the large conformational shift observed in
βPGM.
One of the close neighbors of βPGM, the YqaB family, does not have available structural
data, however, kinetic evidence suggest low levels of βPGM activity (0.1µmol/min) in
addition to its activity as a F1Pase [107]. A homology model of this protein was created
using PHYRE2 [54], resulting in a structure that looks similar to βPGM, yet has only
23% sequence identity [Fig 5.3(e)]. The structural model of YqaB contains a single pinning
residue for the catalytic Asp, a cap domain histidine located 10 residues upstream, similar to
βPGM. The hydrogen bond network Lys-His-Asp that is observed in βPGM is also intact.
The cap-core interface, however, is predicted to be hydrophobic, in contrast to βPGM, which
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may limit the ability of this enzyme to open completely. Synthesis and kinetic profiling of
this target has begun in the Allen lab and structural studies will follow.
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Chapter 6
Appendices
6.1 Appendix I - Parameterization of Sugar Residues
CHARMM27 force field compatible parameters for β-glucose 1,6 bisphosphate, β-glucose
1-phosphate and β-glucose 6-phosphate were constructed by creating patch residues for
the β-glucose (BGLC) scaffold from the CHARMM35 sugar parameter set [67]. Mono-
and di-anionic C6 phosphate patch residues (6P1, 6P2) were constructed by analogy from
parameters and partial charges of the mono- and di-anionic 5'-phosphate-methyl tetrahy-
drofuran (T5PH) from the CGenFF force field parameter set [68]. Mono- and di-anionic
C1 phosphate patches were derived from the PH-B and DPH-B patch residues contained in
the CHARMM36 carbohydrate parameter set [69].
(a)
(b) (c)
Figure 6.1: (a):β-glucose (BGLC) from CHARMM35 parameter set (b):5' methyl-
phosphate tetrahydrofuran (T5PH) from CHARMM27 parameter set which was used
to derive 6' phosphate patch for BGLC (c):glucose 1,6 bisphosphate as created from
BGLC and 6P1 and 1P1 phosphate patches
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PRES 1P1 -1.00
DELE ATOM HO1
!Atom Name Atom Type Partial Charge
C5 CC3163 0.110
H5 HCA1 0.090
O5 OC3C61 -0.400
C1 CC3162 0.110
H1 HCA1 0.090
O1 ON2 -0.620
P1 P 1.500
OT1 ON4 -0.680
O1P1 ON3 -0.820
O2P1 ON3 -0.820
HT1 HN4 0.340
BOND O1 P1 P1 OT1
BOND P1 O2P1 P1 O1P1 OT1 H1
PRES 1P2 -2.00
DELE ATOM HO1
!Atom Name Atom Type Partial Charge
C5 CC3163 0.110
H5 HCA1 0.090
O5 OC3C61 -0.400
C1 CC3162 0.110
H1 HCA1 0.090
O1 ON2 -0.400
P1 P 1.100
OT1 ON3 -0.900
O1P1 ON3 -0.900
O2P1 ON3 -0.900
BOND O1 P1 P1 OT1
BOND P1 O2P1 P1 O1P1
Figure 6.2: Topology files for mono- and di-anionic C1 phosphate patch (1P1 and
1P2)
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6.2 Appendix II - Equilibration of Equilibrium Dynamics Simulations
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Figure 6.4: Backbone RMSD from closed crystal structure (PDB: 1O03) for produc-
tion runs on βPGM in complex with various ligand moeities, showing equilibration
of structural deviation past 50ns.
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